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Abstract 
 
The Immune Inhibitor A1 protease of Bacillus anthracis 
Publication No. _____________ 
Kathryn J. Pflughoeft 
Supervisory Professor: Theresa M. Koehler, Ph.D. 
 
 Bacillus anthracis, an organism ubiquitous in the soil and the causative agent of 
anthrax, utilizes multiple mechanisms to regulate secreted factors; one example is the 
activity of secreted proteases.  One of the most abundant proteins in the culture supernates 
of B. anthracis is the Immune Inhibitor A1 (InhA1) protease.  Here, I demonstrate that 
InhA1 modulates the abundance of approximately half of the proteins secreted into the 
culture supernates, including substrates that are known to contribute to the ability of the 
organism to cause virulence.  For example, InhA1 cleaves the anthrax toxin proteins, PA, 
LF, and EF.  InhA1 also targets a number of additional proteases, including Npr599, 
contributing to a complex proteolytic regulatory cascade with far-reaching affects on the 
secretome.  Using an intra-tracheal mouse model of infection, I found that an inhA-null 
strain is attenuated in relation to the parent strain.  The data indicate that reduced virulence 
of the inhA mutant strain may be the result of toxin protein deregulation, decreased 
association with macrophages, and/or the inability to degrade host antimicrobial peptides.  
 Given the significant modulation of the secretome by InhA1, it is likely that 
expression of the protease is tightly regulated.  To test this I examined inhA1 transcript and 
protein levels in the parent and various isogenic mutant strains and found that InhA1 
expression is regulated by several mechanisms.  First, the steady state levels of inhA1 
transcript are controlled by the regulatory protein SinR, which inhibits inhA1 expression.   
Second, InhA1 abundance is inversely proportional to the SinR-regulated protease 
camelysin, indicating the post-transcriptional regulation of InhA1 by camelysin.  Third, 
InhA1 activity is dependent on a conserved zinc binding motif, suggesting that zinc 
availability regulates InhA1 activity.  The convergence of these regulatory mechanisms 
signifies the importance of tight regulation of InhA1 activity, activity that substantially 
affects how B. anthracis interacts with its environment. 
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1.1. History 
 Bacillus anthracis and the associated anthrax disease have a rich history in infectious 
diseases research. Anthrax and its symptoms, black lesions and blood, were first described 
and named 2,500 years ago by Hippocrates.  B. anthracis was the first bacterium to be 
linked to a disease by C.J. Davaine nearly 150 years ago, work that was later validated by 
Robert Koch (129).  B. anthracis served as the basis for Koch’s postulates, and Louis 
Pasteur used the organism in his early vaccine work (129, 149).  The transmission of B. 
anthracis is primarily a problem in developing nations, with the vaccination of livestock in 
the western world reducing the morbidity and mortality of B. anthracis infections (129, 
149).  The potential use of B. anthracis as a biological weapon has spurred additional 
interest in the molecular and physiological characterization of this organism.  Programs 
studying the weaponization of B. anthracis were initiated during World War I and have 
continued in the subsequent decades.  Fears that the organism would be used as an agent of 
terrorism were realized in 2001 (129). 
 
1.2. Physiology, growth, and lifecycle 
 B. anthracis is a versatile organism that can adapt to a changing environment by 
drastically altering its cell morphology.  The Gram-positive rod-shaped bacilli forms spores 
upon nutrient starvation.  The vegetative form of the bacterium is a large bacillus 3-10 µm in 
length and 1-1.5 µm in width (139).  Growing bacilli are often found in long chains that can 
tangle to form knots or clumps in liquid culture (84) (unpublished data).  The colony 
morphology of B. anthracis is dependent upon growth condition and can appear either dry 
with irregular edges or mucoid in the presence of capsule (84).  The cell envelope is 
composed of the membrane, a thick layer of peptidoglycan that constitutes the cell wall, a 
layer of the cell-wall-associated proteins, Sap and Eag which has been termed the S-layer, 
and a proteinacious capsule (50). The spore form of the bacterium, which is resistant to 
extreme temperature, desiccation, and other environmental challenges, appears as a light 
refractile elongated sphere of 1-2 µm in diameter (139).  Spore proteins belong to one of  
four main structures that are built out from the chromosome-containing core at the center of 
the spore, the cortex, the coat, and the exosporium (37).  As not all species of Bacillus 
possess an exosporium the function of the outermost structure of the spore is not well 
 3 
defined.  The other spore structures are conserved among Bacillus species and function to 
protect the chromosome until nutrients are available allowing for germination and outgrowth 
to vegetative cells (37).    
 In the absence of germination signals, B. anthracis can retain dormancy as a spore 
for extended periods of time.  Upon germination the vegetative form of the bacterium 
readily grows and replicates in a wide array of environments.  In the laboratory, optimal 
growth conditions for B. anthracis are nutrient rich media with aeration at 37ºC, however 
the bacterium can grow in media that contains a variety of carbon sources and at 
temperatures ≤43ºC (84).  In the natural environment, the vegetative form of the bacilli can 
survive in the rhizosphere (126); however the spore appears to be the dominant form in the 
soil.  Low germination frequencies (up to 2%) have been reported for B. anthracis spores in 
soil (72).    
 While the cell can complete its lifecycle from spore to vegetative cell to spore within 
the soil or laboratory media, the lifecycle of B. anthracis often encompasses both in vitro 
and in vivo environments.  This cycle begins with dormant spores gaining entry into a host. 
The spores then germinate, and proliferation of the vegetative cells leads to disease and host 
death.  Upon decay of the host, nutrients are depleted forcing the bacilli to sporulate, 
returning spores to the soil.   
 
1.3. Taxonomy 
 Much of what is known regarding the basic physiology of B. anthracis has been 
inferred from studies performed on the archetype species Bacillus subtilis.  Despite much 
overlap, detailed research into several conserved pathways has outlined important 
phenotypic differences between these species (119, 155) (Chapter IV of this work).  B. 
anthracis is a member of the Bacillus cereus group of closely related organisms, which 
includes Bacillus cereus, Bacillus thuringiensis, and B. anthracis.  Members of the B. cereus 
group have highly conserved chromosomal gene content and synteny, and are thought to 
have a common origin (117).  The B. anthracis genome consists of a 5.2-Mb circular 
chromosome and two large circular plasmids, pXO1 (181.7-kb, including genes encoding 
the toxin proteins) and pXO2 (94.8-kb, including capsule biosynthetic genes) (118).  
Traditionally, one feature that distinguishes B. anthracis from other B. cereus group 
 4 
members is the presence of the virulence plasmids pXO1 and pXO2.  However, recent 
findings indicate that at least one strain of B. cereus harbors a plasmid with similar gene 
content to pXO1 (68).   
 
1.4. Anthrax disease and models of infection 
 B. anthracis is primarily a non-human pathogen, and most anthrax disease occurs in 
land-grazing animals, however humans are susceptible to the disease.  With respect to 
human cases of anthrax there are three different forms of the disease, each of which are 
based upon the route of infection, cutaneous (the most common), inhalational (highest 
lethality rate), and gastrointestinal.  For each route of infection the infectious form of the 
organism is the spore (139).  The working model for inhalational anthrax is that the infection 
can be broken down into three stages: association of spores with phagocytes, spore 
germination, and dissemination of toxin- and capsule-expressing vegetative cells (139) (Fig. 
1-1).  Much remains to be determined with regard to disease progression, including the role 
of immune cells, the timing of germination, and the relative contribution of putative B. 
anthracis virulence factors. 
 As anthrax is a zoonotic disease many animals are susceptible to infection with B. 
anthracis and have been employed as models to study the progression of anthrax disease.  
Classically, rabbits and guinea pigs have been used to model human disease and in vaccine 
development as they have comparable immune systems to that of humans (57).  However, 
mice are often utilized to study infection as they are highly susceptible to infection with B. 
anthracis as well as the effects of anthrax toxin (57).  Differences in the infectivity of 
various mouse strains by B. anthracis and routes of infection have been well documented 
(97) allowing for the efficient use of mice in the study of anthrax disease.   
 
1.5. Virulence factors  
 B. anthracis produces two classic virulence factors, a poly-D-glutamic acid capsule 
and a tripartite toxin (139), as well as several putative virulence factors including a number 
of secreted proteases and the cytolysin anthrolysin O.  Similar to the capsule of many other 
pathogenic bacteria, the B. anthracis capsule is anti-phagocytic, prolonging the survival of  
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Figure 1–1. Model of the progression of inhalational anthrax.  Spores enter the lung 
where they are transported to the regional lymph nodes by alveolar macrophages.  Upon 
germination, vegetative cells multiply and disseminate throughout the body causing 
septicemia as depicted in the high numbers of bacilli in the blood and cerebral spinal fluid of 
the infected host.   
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bacilli within the host (42).  Depolymerization of capsule enhances phagocytosis and killing 
of B. anthracis vegetative cells (130).   
 The B. anthracis tripartite AB toxin consists of two individual A (active or 
enzymatic) moiety toxin proteins, edema factor (EF) and lethal factor (LF), and the B 
(binding) moiety protective antigen (PA) (30).  PA binds to the host-cell anthrax toxin 
receptors (ANTXR1 and ANTXR2), and is processed by a host protease, leading to 
association between host-cell-bound PA and EF and/or LF (6, 9, 66, 153).  Upon association 
of EF and/or LF with PA, the active toxins are translocated into the host cell.  Once 
intracellular, EF and LF interfere with host-cell-signaling through distinct well-defined 
mechanisms (110).  LF inhibits necessary components of host signal transduction pathways 
by cleaving mitogen-activated protein kinases (MAPKs) (19, 66, 110, 120).  EF increases 
the concentration of intracellular cAMP, reducing the activity of the host-cell-signaling 
factors Mek 1 / 2 and ERK, and ultimately causing edema at the site of infection (66, 110).   
 
1.6. Contribution of secreted proteases to bacterial virulence 
 Bacteria secrete proteases as a means to modify their environment, leading to 
enhanced survival and virulence.  With respect to Gram-negative and Gram-positive 
pathogens the secretion of proteases to serve as virulence factors has been well documented 
(64).  Despite extensive study of secreted proteases in other pathogens little is known 
regarding the secreted proteases of B. anthracis.  A classic example of a secreted protease 
that contributes to virulence is the SpeB protease produced by the human pathogen 
Streptococcus pyogenes.  SpeB has a wide range of substrates, including proteins produced 
by the host, such as IgG and extracellular matrix (ECM) proteins, and proteins produced by 
the bacterium, including the cell-wall-anchored M protein and the secreted protein C5a 
peptidase (107, 156).   
 Additional examples of virulence-enhancing secreted proteases are the HA protease 
of Vibrio cholerae, the SspA, SspB, and Aur, proteases of Staphylococcus aureus, and the 
Rgp protease of Porphyromonas gingivalis.  The V. cholerae HA protease both directly and 
indirectly effects virulence by processing host proteins and activating cholera toxin (10, 64).  
In addition to processing bacterial and host proteins, such as ClfB and the heavy chain of 
human immunoglobulin, the S. aureus SspA, SspB, and Aur proteases form a proteolytic 
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cascade whereby each protease activates the zymogen form of the subsequent protease 
(134).  Such a proteolytic cascade represents a highly regulated mechanism of protein 
modification that can impact the extent and timing of protease activity.  The P. gingivalis 
Rgp protease alters the N-terminus of two filamentous surface proteins involved in the 
virulence of the organism, the 75-kDa protein and fimbrilin.  Following secretion and 
cleavage of the signal sequence, Rgp processes the fimbrilin and the 75-kDa protein prior to 
assembly of the mature filaments, such that rgp mutant strains are deficient in filament 
formation (76, 135). 
 Secreted proteases can also indirectly affect the virulence of a bacterium by 
modulating the secretory system. The MycP1 protease of Mycobacterium tuberculosis 
cleaves the EspB protein, a necessary component of the ESX-1 secretory system, such that 
deletion of the protease-encoding gene results in a non-functional secretory apparatus (108).  
Similarly, some but not all effectors secreted by autotransporters are released from the outer 
membrane of Gram-negative bacteria by designated proteases.  An example of this is the 
adhesion protein App that is cleaved by the NalP protease of Neisseria meningitidis, 
releasing the active form of App from the cell (34). 
 
1.7. Secreted proteases of B. anthracis 
 Although extracellular proteases have been demonstrated to play substantial roles in 
the virulence of many pathogens, few of the proteases secreted by B. anthracis have been 
implicated as contributing to the virulence of the organism.  The most studied protease 
secreted by B. anthracis is the anthrax toxin component LF.  LF is a zinc metalloprotease 
that has limited targets in the host, cleaving the Mek3/6, Mek 4/7, and Mek 1/2 MAPKs 
which in turn modulates host signaling pathways (43, 103).   
 The protease Immune Inhibitor A1 (InhA1) has also been implicated in enhancing B. 
anthracis virulence, through the cleavage of an array of substrates.  In work carried out by 
Popov and co-workers, InhA1 was purified and characterized as a neutral zinc 
metalloprotease (28).  Subsequently, InhA1 was found to cleave ECM proteins, including 
fibronectin and type I and type IV collagen using in vitro protease assays (28).  In similar 
experiments, purified InhA1 was demonstrated to cleave proteins involved in the host 
coagulation cascade, including fibrinogen, plasmin inhibitors, and prothrombin (28, 79). The 
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InhA1-mediated cleavage of prothrombin results in the active thrombin protein (79).  
Moreover, in ex vivo experiments examining clot formation, human blood incubated with 
the inhA1 mutant strain had a clotting time that was prolonged compared to blood incubated 
with the parent strain (79).  Finally, InhA1 also appears to modulate levels of a host 
fibrinolysis regulatory protein, Plasminogen Activator Inhibitor (PAI-1), as mice injected 
with purified InhA1 have elevated PAI-1 transcript and protein levels (26).  Taken together 
these data suggest that InhA1 modulates the coagulation cascade in the host, potentially 
impacting dissemination of B. anthracis in the blood.   
 Several additional proteases secreted by B. anthracis have predicted roles in 
pathogenesis (3, 28, 114).  For example, Neutral Protease (NprB or Npr599) has been 
posited to contribute to B. anthracis virulence, as it cleaves laminin and fibronectin (28). 
The sheer abundance of Npr599 in culture supernatant alludes to a potentially significant 
role for the protease in B. anthracis survival in the host or environment.  Npr599 and InhA1 
together account for between 80%-90% of the B. anthracis secretome when the organism is 
grown to stationary phase in Nutrient Broth Yeast extract (NBY) (22).  The secreted protein 
chaperone, HtrA, and the cell-wall hydrolase NlpC/P60, both of which have proteolytic 
activity, are detected in high levels in the plasma of infected animals (131).  In addition to 
freely secreted proteases, B. anthracis also expresses cell-associated proteases, such as 
camelysin (59).  An orthologue of camelysin produced by B. thuringiensis was found to 
cleave the B. thuringiensis toxin protein Cyt2Ba (106).  Whether camelysin, or indeed any 
protease other than LF, contributes to the virulence of B. anthracis remains to be assessed. 
 
1.8. Regulation of the B. anthracis secretome 
 While knowledge of host signaling molecules that induce B. anthracis virulence 
factor expression is limited, virulence factor expression is regulated by the pleiotropic 
virulence gene regulator AtxA
 
when cultured in media containing sodium bicarbonate and 
incubated at elevated CO2 (51, 84). Under such “toxin-inducing” conditions the most 
abundant protein in the B. anthracis secretome is the anthrax toxin protein PA. Interestingly, 
while InhA1 and Npr599 are the predominate proteins in the culture supernates in the 
absence of toxin-inducing conditions, in the presence of toxin-inducing conditions, Npr599 
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levels are below the level of detection in the supernatant, while InhA1 accounts for between 
two and five percent of the secretome late in stationary phase of growth (22).   
 Additional B. anthracis proteins that are prominent in the culture supernatant include 
the S-layer protein Sap and an array of enzymes with proteolytic activity.  Sap is a cell-wall-
associated protein whose abundance in culture supernates is strain and growth condition 
dependent (22, 90).  B. anthracis secretes at least 14 different proteases, the abundance of 
which are largely growth-condition dependent (22).  Many of the proteins secreted in vitro 
are also produced in vivo and are immunogenic, reacting with antibodies produced by B. 
anthracis-infected animals (23).   
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2.1. Strains and culture conditions. B. anthracis strains and plasmids are described in 
Table 2-1.  The virulent Ames strain (pXO1+, pXO2+), attenuated Sterne strain 7702 
(pXO1+, pXO2-), and mutants derived from these strains were used in this study, unless 
otherwise noted.  Escherichia coli strain TG-1 was used as a host for cloning.  E. coli strain 
GM2163 (dam- dcm-) was used to generate a source of unmethylated plasmid DNA.  E. coli 
strain Rosetta pLysS was used for protein expression.  Unless noted otherwise, B. anthracis 
strains were cultured at 37ºC with shaking (200 rpm) in Luria-Bertani (LB) medium with 
0.5% glycerol for RNA and protein isolation, or in Nutrient Broth Yeast (NBY) medium for 
optimal InhA1 protein secretion.  E. coli strains were cultured in LB at 37ºC with shaking 
(200 rpm).  Antibiotics were added as appropriate: Kanamycin (100µg/ml), Spectinomycin 
(100µg/ml for B. anthracis and 50µg/ml for E. coli), Erythromycin (5µg/ml for B. anthracis 
and 150µg/ml for E. coli), Carbenicillin (100µg/ml), and Chloramphenicol (34µg/ml).   
 
2.2. DNA isolation and manipulation. Cloning experiments employing E. coli were 
performed using standard protocols (4).  Plasmid DNA was extracted from E. coli using the 
Wizard Miniprep kit (Promega, Madison, WI) following the manufacturer’s 
recommendations.  Unmethylated plasmid DNA from E. coli strain GM2163 was used for 
electroporation of B. anthracis (85).  DNA was amplified using PCR using Phusion 
Polymerase (New England Biolabs, Ipswich, MA) unless otherwise noted. Oligonucleotide 
primers are described in Table 2-2.  PCR products were purified using the Qiagen gel 
purification kit (Qiagen, Valencia, CA).  Restriction enzymes were purchased from New 
England Biolabs.  T4 DNA Ligase was purchased from Promega. Chromosomal DNA was 
extracted from B. anthracis using the Mo Bio genomic isolation kit (Mo Bio Laboratories, 
Solana Beach, CA). 
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Table 2-1. Strains and Plasmids used in this study 
Strain or Plasmid Characteristica, b Source or Reference
Strains 
Ames Virulent strain, pX01+ and pX02+ Ravel et al 2009
UTA21 sinR- null mutant, derivative of Ames This study
UTA5 UT222 transduced with CP51 propagated on Ames; inhA1 -null mutant, Spcr This study
UTA13 UT324 transduced with CP51 propagated on Ames; npr599  -null mutant , Kanr This study
UTA7 UT282 transduced with CP51 propagated on UTA5; inhA1 inhA2 -null mutant, Spcr, Kanr This study
7702 Sterne strain, pX01+ Guidi-Rontani et al 2001
UT315 sinR -null mutant, derivative of 7702, Spcr This study
UT345 inhA1 -null mutant derivative of 7702 This study
UT356 calY -null mutant derivative of 7702, Spcr This study
UT365 sinI -null mutant derivative of 7702 This study
UT371 sinI sinR- null double mutant derivative of 7702 This study
UT222 inhA1 -null mutant derivative of 7702, Specr This study
UT317 npr599  -null mutant derivative of 7702, Kanr This study
UT368 inhA1 point mutant H374A derivative of 7702 This study
UT379 inhA1 point mutant H374D/E375A derivative of 7702 This study
UT381 inhA1 point mutant E375A derivative of 7702 This study
UT382 inhA1 point mutant E374A/H378D derivative of 7702 This study
UT385 inhA1 point mutant H378D derivative of 7702 This study
UT282 inhA2  -null mutant derivative of 7702, Kanr This study
UT284 inhA1/inhA2 -null mutant derivative of 7702, Kanr Spcr This study
UT306 UT282 derivative, inhA2 gene integrated into the plcR  locus, Kanr Spcr This study
UM23c1-2 ∆secA secA -null derivative of UM23c1-2, Kanr Collin Harwood
UT357 UT356 transduced with CP51 propagated on UM23c1-2 ∆secA ; calY- null mutant, Kanr, Spcr This study
Plasmids
pUTE583 Vector used for allelic exchange, Ermr Chen et al 2004
pHY304 Vector used for markerless deletion, temperature sensitive, Ermr Chaffin et al 2005
pET23d IPTG-inducible expression vector, Apr Novagen
pUTE964 pET28b, SinR N'terminal His-tag This study
pUTE1011 pET28b, npr599  minus signal sequence C'terminal His-tag This study
pUTE973 IPTG-inducible expression vector with hyperspank promoter, Kanr, Ampr This study
pUTE980 pUT973 containing inducible calY This study
a null mutants were created by allelic exchange (Spcr) or markerless mutants
b Spcr - spectinomycin resistant, Kanr - Kanamycin resistant, Ermr - Erythromycin resistant
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Table 2-2. Primers used in this study 
Primers used in this study
Name Sequencea Function
KP95 GTCGACCAACGCCAGCTTTTTCGGC inhA1  markerless mutation
KP96 GGATCCCAGACTGGCCACCCGCTCC inhA1  markerless mutation
KP93 GGATCCGGGTGTACCGAAGTTTGATG inhA1  markerless mutation
KP94 GTCGACGTAAGCGGCGTCAGCTGTTTCG inhA1  markerless mutation
KP116 GTCGACGCTGGCTTCCATATAGTAAAAG calY  allelic exchange
KP117 GGATCCCCTAATTTCTTTTTCAGAC calY  allelic exchange
KP118 GGATCCCCAAGAAGCTGGAGAAG calY  allelic exchange
KP119 CTCGAGCATAGAGGGAGTTTAATGG calY  allelic exchange
KP79 GTCGACGTGTTGTATTTATATAGGTATG sinR  allelic exchange
KP80 GGATCCCTTGAATTTACAAAATGGAAG sinR  allelic exchange
KP81 GGATCCCGTTTTATACGTTCTCCAATC sinR allelic exchange
KP82 GAATTCGTTTAAACGTTTCGATTTTAC sinR allelic exchange
JR109 GAGAGAGCACTATCACTCACC sinR  and sinIR markerless mutation
JR110 GGTGCGCAAATTAATAGAAAGAAGTGCTTACAAACC sinR markerless mutation
JR111 CACTTCTTTCTATTAATTTGCGCACCTTTCTATCAATATG sinR  markerless mutation
JR112 GCGTACAATGGTGATGTACG sinR  markerless mutation
JR107 AGGTATGGGAGTTGCATCAG sinI  markerless mutation
JR108 AGGGAGGAATTACATGTTTGTTCTTTTTAACGAAGTTTATG sinI  markerless mutation
JR105 CGTTAAAAAGAACAAACATGTAATTCCTCCCTAATTATCAATC sinI  markerless mutation
JR106 CAGTTCCTGGTAAAGCTG sinI  and sinIR  markerless mutation
JR114 GGGAGGAATTACATTAATAGAAAGAAGTGCTTACAAACC sinIR  markerless mutation
JR113 CTTCTTTCTATTAATGTAATTCCTCCCTAATTATCAATC sinIR  markerless mutation
KP138 GCCGTCGACCAGCTGTATTAGGCCTTTCATTC inhA1  point mutants 
KP139 CTAAATCATGACCATATTCAGCTGCGAATACACCGACCGC inhA1  point mutant H374A 
KP140 GCGGTCGGTGTATTCGCAGCTGAATATGGTCATGATTTAG inhA1  point mutant H374A 
KP141 GCCTCTAGAGCATAGTTTCTCCACTCAAC inhA1  point mutants 
KP162 GCGGTCGGTGTATTCGCAGATGCATATGGTCATGATTTAG inhA1  point mutant H374D/E375A
KP163 CTAAATCATGACCATATGCATCTGCGAATACACCGACCGC inhA1  point mutant H374D/E375A
KP170 GTATTCGCACATGCATATGGTGATGATTTAGGTTTAC inhA1 point mutant E375A and E374A/H378D
KP171 GTAAACCTAAATCATCACCATATGCATGTGCGAATAC inhA1 point mutant E375A and E374A/H378D 
KP172 CACATGAATATGGTGCTGATTTAGGTTTACCAGATG inhA1  point mutant H378D
KP173 CATCTGGTAAACCTAAATCAGCACCATATTCATGTG inhA1  point mutant H378D
KP95 GTCGACCAACGCCAGCTTTTTCGGC inhA1  markerless mutation
KP96 GGATCCCAGACTGGCCACCCGCTCC inhA1  markerless mutation
KP93 GGATCCGGGTGTACCGAAGTTTGATG inhA1  markerless mutation
KP94 GTCGACGTAAGCGGCGTCAGCTGTTTCG inhA1  markerless mutation
KP71 GGATCCGAAGTAGCAGCAGTTAAGC npr599  allelic exchange
KP72 CTGCAGCGTTTGGTGTTTTTTAAG npr599  allelic exchange
KP73 GTCGACGGGATATTGCTACACTTGAAGAAG npr599 allelic exchange
KP74 GGATCCAACAATATCAGGTTTACTGC npr599 allelic exchange
ES27 ATGAGCTCGGGGAAAAGGGTGGATTAGA inhA1  allelic exchange
ES28 ATGGATCCGGTGTTCCTGTTGCAGGTTT inhA1  allelic exchange
ES29 ATGGATCCGAAGGGACACAATTCAAA inhA1  allelic exchange
ES30 ATGGTACCTCGCAATGCCTCGATTAACT inhA1  allelic exchange
KP03 GTCGACGCTGGAGTAACGACAAATCCA inhA2  allelic exchange
KP08 GGATCCAAGTGGCGCTTTTCTTCTCA inhA2  allelic exchange
KP09 GGATCCCAAGTTGTTGGACAGGCAGA inhA2  allelic exchange
KP10 CTGCAGGGATAATTCCATCATTGTC inhA2  allelic exchange
KP192 biotin-GTGATATACTCGTATGCTAAC inhA1  EMSA probe
KP193 GTTTCTTGTTCATCCCTTATTTC inhA1  EMSA probe
KP79 biotin-GTGTTGTATTTATATAGGTATG calY  EMSA probe
KP117 CCTAATTTCTTTTTCAGAC calY  EMSA probe
nprF biotin-ACCGGAAAGGGGTTTTTCAATATTTG npr599  EMSA probe
nprR GAAAAAGAGTAGTTTCATATTAG npr599 EMSA probe
sipWF biotin-TAACTAATAATTGTAAATTTTCTTATTGC sipW  EMSA probe
sipWR TCTCCGTTGTTTTATATTATTTG sipW  EMSA probe
KP111b CCATGGATTCTAAAAATGTGCTGTCTAC npr599 expression 
KP112 CTCGAGGTTTACGCCAACAGCAC npr599 expression 
KP168 GGGCTAGCATGATTGGAGAACGTATAAAAC sinR  expression 
KP169 GGCTCGAGTTATTTTTGATTTTGCTTCC sinR expression
KP183 GGGTCGACCAGCTAGGGGGAATTGATTG calY expression
KP184 GGGCATGCGTGCTTACAAACCGCACTTC calY expression
a underline indicates a restriction site
b
 Lysine codon optimized for expression in E. coli (CTC to CTG)
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2.3. Construction of B. anthracis mutants.  B. anthracis null strains were constructed as 
allelic exchange mutants or as markerless gene deletion mutants. Allelic exchange mutants, 
in which specific DNA sequences were replaced with a Ω-spectinomycin or Ω-Kanamycin 
resistant cassette, were constructed using pUTE583 as described previously (20).  
Transductants were created as previously described (67).  All mutations were verified with 
PCR and DNA sequencing. 
 Markerless mutations were created using pHY304, a temperature-sensitive vector 
harboring an erythromycin-resistance gene (16).  DNA fragments corresponding to 
approximately 1-kb sequences upstream and downstream of the locus to be deleted were 
cloned in tandem into pHY304.  The DNA inserts for the deletion constructs were generated 
using PCR using EasyA Taq (Stratagene, La Jolla, CA) to amplify upstream and 
downstream sequences separately, or using overlap extension (SOE) PCR to amplify a 
single DNA fragment deleted for the gene of interest (70).  To obtain a markerless mutant, 
the specific pHY304 construct was introduced into B. anthracis using electroporation (127).  
The electroporation mixture was plated on LB medium containing erythromycin and 
incubated at 30ºC for two days to select isolates containing the plasmid.  Clones were 
verified using PCR using Taq Polymerase (NEB, Ipswich, MA), re-streaked on
 
selective 
medium, and incubated at 30ºC.  A single colony was used to inoculate LB broth containing 
erythromycin and the culture was incubated at 30ºC for 16 h.  To obtain an isolate in which  
the pHY304-derivative had integrated into the chromosome using single cross-over 
recombination, the culture was passaged at a 1:100 dilution into LB containing erythromycin 
and cultured at 41ºC (the non-permissive temperature for pHY304) for 10 to 14 h.  
Following a second passage at a 1:1000 dilution in the same conditions, the culture was 
streaked onto selective LB plates and incubated at 41ºC for 10 h.  To promote excision of 
the pHY304-derivative from the B. anthracis chromosome, a single colony of a clone 
harboring an integrated plasmid was inoculated into LB without antibiotic, cultured at 30ºC 
until turbid, and then passaged at a 1:100 dilution multiple times in LB.  Starting with 
passage 3, excision of the pHY304-derivative was assessed by plating serial dilutions of the 
culture on LB agar and incubating at 30ºC for 16 h.  Single colonies were patched to LB 
agar with and without erythromycin and incubated at 37ºC for 16 h.  Erythromycin-sensitive 
isolates were screened for loss of the plasmid and deletion of specific sequences using PCR 
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using Taq Polymerase (NEB, Ipswich, MA) and primers corresponding to DNA sequences 
flanking the locus.  Point mutants were created using SOE and pHY304 for gene 
replacement.   
 
2.4. RNA purification. For transcriptional profiling experiments approximately 1x106 
spores were inoculated into 25ml of LB medium and cultures were incubated until mid-
exponential (OD600 = 0.5-0.6) or early stationary (OD600 = 3.5-3.9) growth phase.  For qRT-
PCR cultures 25ml of NBY was inoculated with vegetative cells at an OD600 = 0.07 and 
were incubated until exponential (OD600 = 0.3-0.45), transition (OD600 = 1.8-2.5), early 
stationary (OD600 = 3.7-5.0), or stationary (OD600 = 4.4-7.4) growth phase.  Six-ml samples 
were taken at exponential phase and 2ml samples were collected at stationary phase.  Cells 
were pelleted at 2,400 x g for 10 min at 4°C. All subsequent centrifugation steps were at 
16,000 x g, 4ºC and samples were kept on ice except where noted.  All but 500µl of culture 
supernate was decanted.  Cells were resuspended and transferred to a 1.5-ml screwcap tube 
containing 500µl of 0.1-mm Zirconia/Silica beads (BioSpec Products, Bartlesville, OK) and 
500µl of acid phenol warmed to 65ºC  (Sigma Aldrich, St. Louis, MO).  The cell suspension 
was subjected to bead beating for 1 min using a Mini BeadBeater (BioSpec Products, 
Bartlesville, OK).  The tube was placed at 65ºC for 5 min, and the bead-beating was 
repeated. Following centrifugation for 3 min, the aqueous phase was transferred to a new 2-
ml tube.  Acid phenol (500µl) was added and the tube was held at room temperature (RT) 
for 5 min followed by vigorous shaking for 15 sec.  Following centrifugation for 3 min, the 
aqueous phase was transferred to a new 2-ml  tube, 0.3 volumes of chloroform was added, 
and the contents were shaken vigorously for 15 sec. The suspension was incubated for 10 
min at RT, inverting frequently to avoid separation of phases.  Following centrifugation, the 
aqueous phase was mixed with 250µl of diethylpyrocarbonate-treated water and 500µl of 
isopropanol. After incubation at room temperature for 10 min, RNA was pelleted using 
centrifugation for 15 min.  Pellets were washed in 75% cold ethanol, air dried, and 
resuspended in 50µl of diethylpyrocarbonate-treated water.  Final concentrations of 
extracted RNA ranged from 700-3,400ng/µl, as determined using a Nanodrop ND-1000 
(Nanodrop Technologies, Wilmington, DE).  20µg of RNA was DNase-treated three times 
using Turbo DNA-free (Ambion, Austin, Tx) according to the specifications of the supplier, 
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and the quality and quantity of RNA was assessed using a Bioanalyzer 2100 system (Agilent 
Technologies, Santa Clara, CA).  RNA was stored at -80ºC. 
 
2.5. Transcriptional profiling. A custom Affymetrix (Affymetrix Inc., Santa Clara, CA) 
microarray containing 16 antisense oligonucleotide probe pairs for each gene in the Ames 
ancestor genome was used for microarray experiments (111).  RNA samples were isolated 
from three independent cultures of each of the strains analyzed (parent and sinR mutant) per 
time point (exponential and stationary phase), giving 12 samples total.  cDNA was created 
from 5.6µg of each RNA sample using random primers and Superscript III according to the 
manufacturers protocol (Invitrogen, Carlsbad, CA).  Following cDNA synthesis, RNA was 
removed by NaOH hydrolysis, and the cDNA purified by phenol/chloroform extraction 
followed by ethanol precipitation.  8µg of each cDNA sample was fragmented using DNase 
I (Promega), biotin-labeled using the Affymetrix genechip labeling reagent (Affymetrix, 
Santa Clara, CA) and TDT (Promega), and hybridized to the microarray (one array per 
cDNA sample).  After overnight incubation with rotation (40°C, 60 rpm), the twelve 
microarrays were washed and scanned using standard Affymetrix protocols.  This research 
was performed in collaboration with Paul Sumby at the Methodist Hospital Research 
Institute in Houston, TX.   
 Gene expression estimates were calculated using Gene Chip Operating System 
(GCOS) v1.4 (Affymetrix, Santa Clara, CA), and data were normalized across samples.  The 
data were transferred from GCOS into EXCEL and analyzed using three independent 
methods.  For manual analysis, EXCEL was used to subtract background (signal intensities 
of <50), the signal for each gene was averaged across the three replicates per strain per time 
point, and the fold-change (parent/sinR mutant) was determined.  Two programs, Arraystar 
(DNAstar, Madison, WI) and dCHIP (Wing Wong and Cheng Li Labs, Harvard, Cambridge, 
MA) were used to confirm differential gene expression.  For the Arraystar analysis, raw data 
were imported from EXCEL and fold-change was determined for each gene, with those 
greater than two-fold being reported.  Similarly, for dCHIP analysis, raw data were imported 
from EXCEL, a background signal of 100 was subtracted, fold-change was determined, and 
genes with a fold-change of greater than 1.5 were reported.  The raw data were deposited at 
the MIAME compliant Gene Expression Omnibus (GEO) database at the National Center 
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for Biotechnology Information (http://www.ncbi.nlm.nih.gov/geo) and are accessible 
through accession number GSE22559. 
Changes in gene expression of sipW (GBAA1287), tasA (GBAA1288), calY 
(GBAA1290), and GBAA_pX02_0023 were confirmed using semi-quantitative RT-PCR.  
PCR reactions used gene specific primers, cDNA made as described above, RNA controls, 
or DNA controls (41).  The 16S gene amplified from cDNA was used as a loading control.  
Changes in inhA1 (GBAA1295) were confirmed using quantitative RT-PCR. 
 
2.6. Quantitative RT-PCR.  Specific quantitative assays for inhA1 and inhA2 were 
developed using Beacon Designer, AlleleID (Premier Biosoft), or RealTimeDesign 
(Biosearch Technologies) software based on the Bacillus anthracis Ames strain sequence 
from NCBI.  Real-time qPCR assay information is provided in Table 2-3.   
“cDNA was synthesized in 5µl total volume by the addition of 3 µl/well RT 
master mix consisting of: 400 nM assay-specific reverse primer, 500µM 
deoxynucleotides, Superscript II buffer and 1 U/µl Superscript II reverse 
transcriptase (Invitrogen, Carlsbad, CA), to a 96-well plate (ISC Bioexpress, 
Kaysville, UT) and followed by a 2µl volume of sample (25 ng/µl).  Each 
sample was assayed in triplicate plus a control without reverse transcriptase to 
access DNA contamination levels.  Each plate also contained an assay-specific 
sDNA (synthetic amplicon oligo) standard spanning a 5-log template 
concentration range and a no template PCR control.  Each plate was covered 
with Biofilm A (Bio-Rad, Hercules, CA) and incubated in a PTC-100 
thermocycler (Bio-Rad, Hercules, CA) for 30 min at 50°C followed by 72˚C for 
10 min.  PCR master mix, 15 µl/well, was added directly to the 5µl RT volume.  
Final concentrations for the PCR were 400 nM forward and reverse primers 
(IDT, Coralville, IA), 100nM fluorogenic probe (Biosearch Technologies, 
Novato, CA), 5mM MgCl2, and 200µM deoxynucleotides, PCR buffer, 150nM 
SuperROX dye (Biosearch Technologies, Novato, CA) and 0.25U JumpStart 
Taq polymerase per reaction (Invitrogen, Carlsbad, CA).  RT master mixes and 
all RNA samples and DNA oligo standards were pipetted using a Tecan Genesis 
RSP 100 robotic workstation (Tecan US, Research Triangle Park, NC); PCR 
master mixes were pipetted utilizing a Biomek 2000 robotic workstation 
(Beckman, Fullerton, CA). Each assembled plate was covered with optically 
clear film (Applied Biosystems, Foster City, CA) and run in a 7900 real-time 
instrument using the following cycling conditions: 95°C, 1 min; followed by 40 
cycles of 95°C, 12 sec and 60°C, 30 sec.  Data were analyzed using SDS 2.3 
(7900) software (Applied Biosystems, Foster City, CA) with FAM reporter and 
ROX as the reference dye.  Synthetic, polyacrylamide gel electrophoresis 
(PAGE) -purified DNA oligos used as standards (sDNA) encompassed at least 
the entire 5’ – 3’ amplicon for the assay (Sigma-Genosys, The Woodlands, TX).  
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Table 2-3. qRT-PCR primers and probes used in this study 
Name
Sequence                                                                                                                                                                                                                                               
(and nucleotide in relation to start codon (and strand))
Accession
number
PCR 
Efficiency 
(%)
Limit of 
detection 
(copies)
Length of 
product
(bases)
gyrB  F ACTTGAAGGACTAGAAGCAG (54(+)) NC_003995 98% 218 67
gyrB  R GTCCTTTTCCACTTGTAGATC (121(-)) NC_003995 98% 218 67
gyrB  probe CGAAAACGCCCTGGTATGTATA-BHQ1 (76(+)) NC_003995 98% 218 67
inhA1 F TATAGCGGTCATGGTGAACCAG (1168(+)) NC_003997 97% 154 95
inhA1 R GAGAAACTTGTTGGCGTCGTTC (1262(-)) NC_003997 97% 154 95
inhA1  probe TTTACCTGCCCAGCTTCCGCCGC-BHQ1 (1233(-)) NC_003997 97% 154 95
inhA2  F ATAGCTTTAAAGATAACTGGGTTG (2036(+)) AE026879 95% 187 78
inhA2  R GCTTCTGGATGAGAGTCTACA (2111(-)) AE026879 95% 187 78
inhA2  probe CAAGGAATCCTTCACCTGGATGCACC-BHQ1 (2086(-)) AE026879 95% 187 78
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Each oligo standard was diluted in 100 ng/µl E. coli tRNA-H2O (Roche 
Diagnostics, Indianapolis, IN) and spanned a 5-log range in 10-fold decrements 
starting at 0.8 pg/reaction.  Due to the inherent inaccuracies in quantifying total 
RNA using absorbance, the amount of RNA added to an RT-PCR from each 
sample was more accurately determined by measuring the amount of at least 
one transcript that was invariant across all samples.” 
 
Methods for quantitative RT-PCR were communicated by Gregory Shipley at the University 
of Texas, Health Science Center, Houston.   Final data were normalized to the previously-
used housekeeping gene gyrB (41).  This research was performed in collaboration with 
Gregory Shipley at the University of Texas, Health Science Center, Houston. 
 
2.7. Coomassie and Western blot analysis. To assess cell-associated and freely-secreted 
protein levels, 2ml culture samples were centrifuged at 6,000 x g for 5 min. Cell pellets were 
stored at -20ºC until ready for use, at which time they were thawed on ice and resuspended 
in 75µl resuspension buffer (50mM Tris, 3mM sodium azide, pH 7.6) and 75µl 2x SDS 
loading buffer (25% 0.5M Tris pH 6.8, 2.5% SDS, 20% glycerol, 0.05% β-mercaptoethanol, 
0.02% Bromo Blue).  
 Culture supernates were filtered through a 0.22-µM filter (Nalgene, Rochester, NY).  
To assess proteases in the supernatant, proteins were precipitated using deoxycholate and 
trichloroacetic acid (21) at 0.01% and 15%, respectively, and incubated on ice for 30 min or 
stored at -20ºC overnight.  Frozen supernatant samples were thawed on ice and precipitated 
protein was pelleted at 16,000 x g for 20 min at 4ºC.    Protein pellets were washed with 1ml 
of cold acetone at -20 ºC, and incubated on ice for 10 min.  Precipitated protein was then 
pelleted as above.  The acetone was removed, and pellets were air-dried for 5 min before 
resuspending in 50µl of resuspension buffer and 50µl of 2x SDS loading buffer.  To assess 
toxin proteins in the supernatant, culture supernatant samples were filtered and prepared by 
mixing supernatant in a 1:1 ratio with 2x SDS loading buffer. 
 Peptides from InhA1, Npr599, and camelysin that were chosen as antigens for 
antisera production were predicted as surface exposed amino acids by Genscript 
(Piscataway, NJ).  α-InhA1, α-Npr599, and α-camelysin antibodies against peptides 
LPDKDIKTIDPAFG, EYYDNRNPDWEIGEC, and TLADLQKTDPDLLA, respectively, 
were generated in rabbits, in collaboration with Genscript (Piscataway, NJ).  α-InhA1, α-
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Npr599, and  α-camelysin antisera was purified using Pierce Nab Spin Columns as per 
manufacturers instructions (Thermo Scientific, Rockford, IL).  α-TasA (raised against 
purified TasA from B. subtilis) was a gift from Adam Driks (Loyola University).  Protective 
Antigen, Lethal Factor, and Edema Factor poly-clonal antibodies were obtained from the 
John Collier Laboratory (Harvard Medical School).  SodA-1 antibodies were obtained from 
BEI Resources (ATCC, Manassas, VA).  
Samples derived from culture supernates and cell pellets were subjected to SDS-
PAGE.  Gel-imbedded proteins were stained with Coomassie Blue (G-250) or transferred to 
a nitrocellulose membrane using a semi-dry blotter at 300 mAmps for 20 min using Towbin 
buffer (3.94g Tris base, 14.4g Glycine, and 20% Methanol) prior to Western hybridization 
analysis.  Membranes were blocked in TBS-T (20mM Tris base, 137mM NaCl, 0.1% 
Tween 20 [pH 7.6]) with 3% BSA for 1 h at RT prior to exposure to primary antibody for 1 
h.  α-InhA1, α-Npr599, α-LF, α-EF and α-Camelysin antisera were used at a concentration 
of 1:1,000 in TBS-T, unless otherwise noted; α-TasA  and α-PA antibody was used at 
1:5,000; and α-SodA-1 was used in a 1:50,000 dilution in TBS-T.  Membranes were rinsed 
in TBS-T three times for 5 min each, and then exposed to HRP-conjugated goat α-rabbit 
antibody (Bio-Rad, Hercules, CA) at a concentration of 1:100,000 for 1 h at RT.  
Membranes were rinsed as above, developed using the Pierce SuperSignal West 
Dura Extended Duration Substrate (Thermo Scientific, Rockford, IL), and exposed to 
chemiluminescent light for detection. 
 
2.8. Secretome analysis using 2D gels.  B. anthracis strains 7702 and UT345 were cultured 
for optimal InhA1 production in a 30ml volume.  Cells were pelleted at 2,400 x g for 10 min 
at 4ºC.  The culture supernatant was concentrated ~50x using a centrifugal concentrator, 
Centricon-15, with a 30-kDa size exclusion (Millipore, Billerica, MA).  Protein 
concentration was assessed using the Pierce BSA assay (Thermo Fisher Scientific, 
Rockford, IL) as described by the manufacturer in 20µl volume.  Optical density of samples 
was assessed using a Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE).  The 
protein was TCA precipitated (as described above) omitting resuspension of the protein.  
Protein pellets were shipped to Applied Biomics for analysis using Differential In Gel 
Electrophoresis (DIGE).  DIGE involves the Cy3-labeling of one population of proteins (e.g. 
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from the parental strain), the Cy5-labeling of a second group of proteins (e.g. from the 
inhA1-null strain), and the mixing and separation of both protein sets on the same gel via 
2D-gel electrophoresis to enable quantification of relative protein abundance on a 
secretome-wide scale.  Protein spots were quantified using the software DeCyder 2D version 
6.5 (GE Healthcare, Piscataway, NJ).  Gel plugs were picked and returned for identification.  
This research was performed in collaboration with David Engler at the Methodist Hospital 
Research Institute in Houston, TX.   
 
2.9. Mass Spectrometry.  Samples were processed for peptide and protein identification via 
tandem mass spectrometry and subsequent database search essentially as previously 
described (60), with some modifications.  Briefly, 2D gel spots were subjected to manual in-
gel trypsin digestion and peptide recovery, followed by analysis of resulting tryptic peptides 
using MALDI-MS/MS on a Synapt HDMS mass spectrometer (Waters, Milford, MA) 
operated in the data-dependent acquisition mode.  Protein Lynx Global Server (PLGS v2.4; 
Waters, Milford, MA) was used as the search engine to search the MS and MS/MS data 
against an extracted B. anthracis Ames ancestor database from NCBI (NCBI release v175.0; 
containing 11,152 protein entries for B. anthracis Ames ancestor).  
 To assess the purity of our purified InhA1 sample (see below) we used LC/MSE.  
The purified InhA1 sample was subjected to in-solution trypsin digestion, and the resulting 
tryptic peptides were chromatographically separated over a 75µm id C-18 column on a 
Waters NanoAcquity UPLC (Waters, Milford, MA).  Separated peptides were introduced 
via nanoelectrospray ionization into the Synapt mass spectrometer (Waters, Milford, MA).  
Peptide analysis was carried out with the mass spectrometer operating in the data-
independent (MSE) mode of operation, taking advantage of the parallel fragmentation 
capabilities of the Synapt instrument.  Peptide identification via database search was carried 
out as described above using the PLGS software. This research was performed in 
collaboration with David Engler at the Methodist Hospital Research Institute in Houston, 
TX.   
 
2.10. Amino-Terminal Sequencing.  Proteins were separated using SDS-PAGE and 
transferred to PVDS membrane using a semi-dry blotter at 300V for 1 h in Towbin buffer.  
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Protein bands were stained with R-Coomassie blue, destained, and cut from the membrane.  
The N-terminal sequences of the proteins were sequenced using Applied Biosystems Procise 
cLC Sequencing system (Model 492cLC, Life Technologies, Carlsbad, CA) in collaboration 
with Richard G. Cook at the Baylor College of Medicine Protein Chemistry Core facility.   
 
2.11. Purification of recombinant B. anthracis SinR.  Recombinant SinR protein (rSinR) 
was purified from E. coli using a protocol modified from Kearns et al. (80). Briefly, DNA 
containing the sinR coding sequence was amplified using PCR using primers KP168 and 
KP169.  The PCR product was cloned into the NheI and XhoI restriction sites of expression 
vector pET28b (Novagen, Gibbstown, NJ) to create an inducible gene encoding a thrombin-
cleavable amino-terminal His-tagged SinR protein.  The plasmid, pUTE964, was 
transformed into the E. coli Rosetta strain expressing pLysS and grown in 600ml of LB 
broth to an OD600 of approximately 0.8.  IPTG (1mM final concentration) was added and 
incubation continued for 3 h.  Cells were pelleted using centrifugation (10 min at 1,370 x g), 
resuspended in 10.8ml of lysis buffer (20mM Tris, 2mM EDTA, pH 8.0), and frozen at -
80ºC.  Following three cycles of freeze/thaw, cell debris was pelleted at 16,000 x g at 4ºC 
for 20 min.  The supernatant fraction was mixed with 1ml of NTA-Ni Agarose beads 
(Qiagen) rotating at 4ºC for 1 h, and unbound protein was removed from the beads in five 
washes (5X bed volume each) with wash buffer (50mM Tris HCl, 500mM NaCl, and 20mM 
imidazole, pH 8.5).  Beads were pelleted at 1,370 x g for 5 min.  The NTA-Ni agarose beads 
and associated protein were resuspended in 1ml of elution buffer (10mM Tris HCl, 10mM 
MgCl2, 1mM EDTA, 0.3mM DTT, 5% glycerol, 1mM PMSF, pH 8.5), and bound protein 
was released from the beads using biotinylated thrombin (4.2µl; Novagen, Gibbstown, NJ) 
in a 16 h reaction rotating at RT.  The protein slurry was loaded on a column and rSinR and 
Thombin were eluted using gravity-flow.  Biotinylated thrombin was removed from the 
rSinR using absorption to streptavidin-agarose beads in a 1 h reaction rotating at RT.  
Thrombin-bound beads were pelleted at 16,000 x g at 4ºC for 20 min and supernatant 
containing rSinR was removed.  Purified rSinR was dialyzed overnight at 4ºC in 10mM Tris 
HCl containing 50mM NaCl, 1mM EDTA, 5% glycerol, and 1mM DTT at pH 8.5.  Protein 
purity was assessed following 12% SDS-PAGE and Coomassie Blue staining. Protein 
concentration was determined using OD280 and protein was stored at -80ºC.   
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2.12. Purification of InhA1. The InhA1 protease was purified from the supernatant of B. 
anthracis strain UM23C1-2 ∆secA/calY (UT357) cultured in 1 L of NBY medium, divided 
into two 2-L bevelled flasks at 37ºC with shaking for 14 hours.  The culture was centrifuged 
at 2,400 x g for 10 min at 4ºC.  The resulting culture supernatant was filtered through a 0.22-
µM PES filtration devise (Nalgene, Rochester, NY) and concentrated approximately 50-fold 
using a centrifugal concentrator, Centricon-70, with a 30-kDa size exclusion (Millipore, 
Billerica, MA) and dialyzed against buffer A containing 50 mM Tris-HCl (pH 7.6), 50 mM 
NaCl, and 3 mM sodium azide at 4ºC.  After passing through a 0.22 µM SFCA filter 
(Nalgene, Rochester, NY), the protein sample was loaded onto a HiTrap Q HP column (GE 
Healthcare, Piscataway, NJ) equilibrated with 20 mM Tris-HCl (pH 8) and 50 mM NaCl.  
The column was washed with the same buffer and proteins were eluted with a linear gradient 
of 50 mM to 1M NaCl in 20 mM Tris (pH 8) using an AKTA Purifier system (GE 
Healthcare, Piscataway, NJ). Eluted proteins were analyzed using SDS-PAGE. Gels were 
stained with Coomassie or proteins were transferred to nitrocellulose for Western 
hybridization using antibodies specific to InhA1.  Fractions determined to contain InhA1 
(eluted at 228-304 mM NaCl) were combined and further concentrated to approximately to 
~ 1ml at a concentration of 4.6 mg/ml using an Amicon Ultra-15 centrifugation filter 
(Millipore, Billerica, MA) with a 30kDa cut-off.  Purity was assessed using LC/MSE as 
described above.  This work was performed in collaboration with Hye Jeong Yeo at the 
University of Houston. 
 
2.13. Purification of rNpr599.  npr599 (GBAA0599) was amplified using PCR using 
KP111 and KP112 and was cloned into the into the NcoI and XhoI restriction sites of 
expression vector pET23d (Novagen, Gibbstown, NJ), generating a C-terminal His-tagged 
protein.  The rNpr599 was subsequently expressed and purified from E. coli using affinity 
purification to NTA resin (Qiagen, Valencia, CA).  Unbound protein was washed from the 
resin with 50mM NaH2PO4, 300mM NaCl, 50mM Imidazol at pH 8.  Bound protein was 
subsequently eluted with 50mM NaH2PO4, 300mM NaCl, 250mM Imidazol at pH 8.  The 
purity of the eluted protein was assessed using Coomassie staining and Western blot analysis 
with Npr599-specific antibodies.   
 
 24 
2.14. In vitro protease assays.  Purified InhA1 was mixed with substrate (rPA, rEF, rLF, 
rNpr599, or rSodA-1) in protease buffer (50mM Tris, 100mM NaCl, 1mM CaCl2, 1mM 
MgSO4, pH 7.8) and incubated at 37ºC for set time points.  Reactions were then placed on 
ice and EDTA added to a final concentration of 50mM to stop the reaction.  2X SDS-buffer 
was added, samples were boiled for 5 min, separated using SDS-PAGE, and analyzed using 
Western blot with substrate-specific antibodies.   rPA, rLF, and rSodA-1 from B. anthracis 
were obtained from BEI Resources (ATCC, Manassas, VA).  rEF was obtained from List 
Biological Laboratories (List Biological Labaoratories, Campbell, CA ).  rNpr599 was 
purified as described above.  
 
2.15. Electrophoretic mobility shift assays.  Electrophoretic mobility shift assays 
(EMSAs) were performed using the Pierce Light Shift EMSA kit (Thermo Fisher Scientific, 
Rockford, IL). Biotinylated DNA probes used in these studies corresponded to the promoter 
regions of three genes implicated as SinR targets in microarray experiments, sipW, calY, and 
inhA1, npr599. Probes were generated using PCR using biotinylated primers (Table 2-2) and 
purified using the Qiagen gel purification kit. Probe (0.1nM) and 2µg of poly (dI-dC) were 
added to reaction buffer (10mM Tris, 50mM KCl, 1mM Dithiothreitol, 0.1% NP-40, and 
20mM MgCl2, pH 7.5).  Five reactions were set-up for each probe tested, with one reaction 
receiving no rSinR protein, and the remaining four reactions containing increasing 
concentrations of rSinR protein (0.4, 2.0, 10, and 50nM). Samples were incubated at 37ºC 
for 35 min and then electrophoresed in a TBE gel containing 5% bis-acrylamide at RT for 1 
h at 100V.  DNA was transferred from the gels to nitrile membranes using a semi-dry 
apparatus (280 mA for 13 min).  Following cross-linking of the DNA to the membrane using 
a UV cross-linker (UVC500, GE Healthcare, Piscataway, NJ), membranes were blocked, 
washed, and developed according to the Pierce Light Shift EMSA kit protocol (Thermo 
Fisher Scientific, Rockford, IL).   
 
2.16. IPTG-inducible expression of camelysin in B. anthracis.  Plasmid 
pdr111Hyperspank (12) containing the IPTG-inducible promoter Phyperspank, was modified as 
follows for use in B. anthracis.  The ori1030 from pHT304 (36) was cloned in the BamHI 
restriction site.  The spectinomycin resistance gene was replaced with an Omega cassette 
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carrying a kanamycin-resistance gene, by digesting the vector with EcoRI and SacII, and 
inserting ΩKan, creating pUTE973 (Table 1).  The calY gene, carrying its native ribosomal 
binding site, was amplified from B. anthracis genomic DNA with primers KP183 and 
KP184 (Table 2-2), and cloned into the SalI and SphI restriction sites of pUTE973 such that 
transcription of the calY gene was driven by the IPTG-inducible promoter. The calY 
expression vector was named pUTE980 (Table 2-1).  Camelysin and InhA1 levels produced 
by each strain were assessed using Western blot analysis.  Where indicated, densitometry 
was utilized to quantify the signal intensity of protein bands. 
 
2.17. India ink exclusion assay.  Capsule levels were assessed using an india ink exclusion 
assay as previously described (41).  Briefly, cells were cultured in NBY with sodium 
bicarbonate and 5% CO2 to the exponential phase of growth and mixed on a microscope 
slide with india ink.  Samples were then examined under 100X microscopy using a Nikon 
Eclipse TE2000-U microscope (Nikon, Melville, NY).  Images were taken using Metamorph 
(Imaging Series 6.1) software (Molecular Devices, Sunnyvale, CA).  Capsule expression is a 
reflection of the size of the halo of ink particles excluded from the bacilli.  
 
2.18. Heat resistance assays.  Suspensions of B. anthracis cells were incubated at 65ºC for 
90 min.  Serial dilutions of cell suspensions were plated on LB plates +/- heat treatment and 
incubated overnight at 37ºC and colony forming units (CFUs) were enumerated.  The 
percentage of heat resistant spores was determined by the formula: (number of CFUs after 
heat treatment / number of CFUs before heat treatment) x 100.  Heat resistant spores are a 
reflection of the number of spores that are not undergoing sporulation or germination.   
 
2.19. Macrophage infections.  J774A.1 mouse macrophage-like cells were infected at a 
multiplicity of infection (MOI) of 10 with spores of B. anthracis strains 7702 or inhA mutant 
derivatives.  Infections took place for 30 minutes and were incubated at 5% CO2 at 37º C in 
Difco modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA) without the addition of 
fetal bovine serum (FBS, Invitrogen, Carlsbad, CA).  Spores that were not attached to, or 
engulfed by, macrophages were washed out of the wells with 3 PBS rinses (Invitrogen, 
Carlsbad, CA).  A 30 min gentamicin treatment was then applied to kill any germinated 
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spores that were extracellular to the macrophage.  Gentamicin was washed from the cells 
with PBS and fresh DMEM containing 5% FBS applied.  Samples were taken at 0, 3, 6, and 
8 h post-infection.  At each time-point two cell populations were examined.  The first 
population consisted of all the bacilli in the infection (macrophage-associated and bacilli 
that were free in the media).  The second population consisted of macrophage-associated 
bacilli only, and was obtained by applying a second gentamicin treatment to kill any 
germinated spores in the media.  After disruption of the macrophage monolayer by cell 
scraping, serial dilutions were plated on LB plates without antibiotic in duplicate.  Plates 
were incubated overnight at 37ºC with CFUs enumerated the following day.  J774A.1 mouse 
macrophage-like cells were a gift from Jeffrey Actor (University of Texas, Health Science 
Center, Houston). 
2.20. In vivo studies.   BALB/c mice were infected with a fully virulent strain (Ames) of B. 
anthracis or inhA isogenic mutant via intratracheal inoculation, as previously described (97).  
Briefly, inoculations were made through a small incision in the skin and spores were 
injected directly into the trachea.  Infection was assessed using LD50 and mean time-to-
death.  The LD50 (the concentration of bacteria required to kill 50% of infected animals) of 
the Ames and inhA mutant strains was determined by infecting groups of 10 mice with 
increasing concentrations of spores starting at 1x102.  The LD50 of the Ames strain was 
previously determined to be 1x103 (42).  For time-to-death experiments, mice were infected 
with a range of doses (low dose = 1x102 to a high dose = 1x104 ) and signs of infection were 
evaluated over time.  In all experiments, a negative control group of mice were generated by 
inoculation with saline. Two independent experiments were carried out, with infections 
initiated on different days.  Experiments were performed in collaboration with Dr. C.R. 
Lyons (University of New Mexico). 
 
2.21. Minimal inhibitory concentrations. Minimal inhibitory concentrations were 
determined for various antimicrobial peptides using a radial diffusion assay as previously 
described (Lisanby et al 2008).  Briefly, the Ames strain or inhA1/2 mutant derivative was 
seeded within two layers of agarose and dilutions of the peptide of interest were imbedded 
within wells bored into the agarose.  Cells were grown to confluency at 37ºC, and zones of 
 27 
clearance around the peptides were measured to enable calculation of minimal inhibitory 
concentrations.   
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Chapter III 
Modulation of the Bacillus anthracis secretome by the  
Immune Inhibitor A1 protease 
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3.1. Introduction 
Cleavage of extracellular substrates by secreted proteases is one method by which 
bacteria modulate their environment to promote survival and/or proliferation. Secreted 
proteases of pathogens can inactivate essential host proteins or cleave anti-microbial host 
factors (108, 156). Proteolysis of extracellular proteins by environmental bacteria can result 
in peptides that serve as growth substrates or are used in cell-cell communication (1, 122).  
Substrate specificity of secreted bacterial proteases can be highly variable. For 
example, collagenases produced by various Clostridium species cleave a single substrate, 
while the Streptococcus pyogenes SpeB protease is active against a large number of proteins 
(44, 77). Three of the four classes of secreted bacterial proteases are distinguished by the 
catalytic residue(s) within their active sites. These are the serine, aspartate, and cysteine 
proteases (64, 123). The fourth class, the metalloproteases, require metal ions for activity. 
The most common bacterial metalloproteases contain zinc in the active site and harbor a 
conserved HEXXH zinc-binding sequence (64, 69). 
 Bacillus anthracis, a soil bacterium that is the etiological agent of anthrax, has a 
complex “secretome”, or population of secreted proteins, that includes many proteases and 
other degradative enzymes. Published studies employing two-dimensional electrophoresis 
and mass spectrometry analyses of culture supernates have revealed large differences in the 
levels of some of these enzymes when B. anthracis cells are cultured in different conditions 
(2, 22, 71, 90). The most notable example is lethal factor (LF), one of the three anthrax toxin 
proteins. LF, a metalloprotease, and the other (non-proteolytic) toxin proteins, protective 
antigen (PA) and edema factor (EF) are induced in media containing bicarbonate and 
incubated in elevated CO2 (51, 84).  During growth in toxin-inducing conditions the toxin 
proteins accumulate to high levels in the culture supernates but are in relatively low amounts 
in cells grown under atmospheric conditions.  Elevated CO2 and bicarbonate signals are 
considered to be an important cue for the bacterium during infection of mammalian host 
tissues.  In contrast to the LF protease, chitin related proteins are abundant in culture 
supernates of B. anthracis grown in air, but less abundant in supernates from cells cultured 
in toxin inducing conditions (22 52), possibly reflecting a function for these degradative 
enzymes B. anthracis encounters the soil environment. 
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 Among the most abundant proteins identified in B. anthracis culture supernatants are 
the neutral protease Npr599 (also known as NprB) and the zinc metalloprotease Immune 
Inhibitor A1 (InhA1) (22). Npr599 is highly abundant in supernates of cultures grown in air, 
however is nearly absent when cultured with CO2/bicarbonate, whereas high levels of InhA1 
are apparent in both growth conditions (22).  There have been few reports describing activity 
of the B. anthracis Npr599 protein. Studies of InhA1 function have centered on its potential 
role as a virulence factor. InhA1 has been reported to cleave extracellular matrix proteins, 
such as collagen and fibronectin (28), and to modify components of the coagulation cascade 
including fibrinogen, plasminogen activator inhibitor (PAI-1) and prothrombin (26, 28, 79). 
A role for InhA1 in thrombosis is apparent from ex vivo experiments demonstrating that B. 
anthracis-induced clotting of human blood was delayed in a strain deleted for the InhA1 
gene (79).  The affects of InhA1 on coagulation would likely impact bacterial dissemination 
within the host.  
Here, I use a proteomic approach to demonstrate that InhA1 activity drastically alters 
the composition of the B. anthracis secretome, including the anthrax toxin proteins.  My 
data indicate that InhA1 functions within a proteolytic regulatory cascade, modulating the 
abundance of Npr599, and at least nine additional secreted proteases.  The potential 
importance of this proteolytic cascade with respect to B. anthracis virulence and survival is 
discussed.  
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3.2. Results 
3.2.1. InhA1 modulates the B. anthracis secretome.  Supernate protein preparations from 
stationary phase cultures of the parent strain 7702 and the isogenic inhA1-null mutant 
UT345 were subjected to SDS-PAGE analysis with Coomassie staining.  Despite the 
comparable growth rates and optical intensities of the cultures, the abundance of protein in 
the culture supernate of the inhA1 mutant exceeded that of the supernate from the parent 
strain culture, as shown in a Coomassie-stained gel (Fig. 3-1A). Proteins associated with 
bands showing significantly altered densities were identified using MALDI-MS/MS. 
Proteins exhibiting increased levels in the inhA1 mutant included those annotated as ABC 
transporters (GBAA1191 and GBAA2041) a GroEL chaperone (GBAA0267), the S-layer 
protein Sap (GBAA0885), a sulfatase (GBAA5470), and a serine protease (GBAA3660) 
(118). In addition, the data indicated that the protease Npr599 (GBAA0599) had an altered 
molecular weight in the parent and mutant strain samples (Fig. 3-1A), suggesting InhA1-
dependent processing of Npr599.  
 Given the large number of changes apparent in the one-dimensional electrophoretic 
analysis, differential in-gel electrophoresis (DIGE) experiments were performed to facilitate 
direct comparison of the parent and inhA1 mutant supernate protein profiles.  Differentially 
labeled protein preparations were mixed and subjected to two-dimensional SDS-PAGE (Fig. 
3-2). Of the 1,340 protein spots identified using DIGE analysis, only 461 spots, 
approximately one third, fluoresced yellow, indicating that the proteins were present in 
equal amounts in supernates from both strains. Of the 879 remaining protein spots, 463 were 
identified as less abundant in the inhA1 secretome (fluoresced green) and 416 were 
identified as more abundant (fluoresced red).   
 I chose 96 spots for MS/MS analysis: 10 exhibiting equal abundance in the two 
strains and 86 which showed a ≥9-fold change between the parent and mutant strains (17 
were less abundant in the mutant and 69 were more abundant in the mutant). Of the 96 spots 
tested, 51 unique protein identifications were made (Table 3-1 and Fig. 3-2). Multiple 
proteins were represented as more than one spot, indicating multiple isoforms and/or sizes. 
Proteases were strongly represented among the altered proteins, suggesting that a proteolytic 
cascade, whereby one protease regulates the activity of a second protease, which regulates 
the activity of a third protease, etc., and that the proteolytic cascade was responsible for the  
 32 
  
 
Figure 3-1. Disruption of InhA1 activity through deletion or mutation alters the 
protein pattern of B. anthracis.  Parent strain 7702, inhA1 null mutant UT345, and five 
7702-derivatives containing point mutations within the inhA1 zinc-binding motif (H374A, 
H374D/E375A, E375A, E375A/H378D, and H378A) were cultured to stationary phase.  
Supernates were collected and subjected to SDS-PAGE.  (A) Coomassie stained gel of 
secreted proteins. Bands identified as InhA1 in the parent and the H374A and E375A mutant 
strains are designated with an asterisks.  Bands determined to be Npr599 are boxed.  (B)  
Western blot analysis with InhA1 specific antibodies.   
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Figure 3-2. Deletion of inhA1 significantly alters the B. anthracis secretome.  Cy3-
labeled supernatant proteins from parental strain 7702 and Cy5-labeled supernatant proteins 
from isogenic inhA1 null mutant strain UT345 were mixed and separated using 2D-gel 
analysis.  Red spots represent proteins more abundant in the mutant strain.  Green spots 
represent proteins less abundant in the mutant strain.  Yellow spots represent proteins that 
are present in equal abundance in the supernatants of the parental and mutant strains.  
Numbered and circled protein spots were extracted and subjected to mass spec analysis – see 
Table 3-1. 
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Table 3-1. Proteins identified from proteomic analysis.    Proteins are listed by ascending 
gene number.   
Sample (a) 
Gi 
Accession (b) GBAA# (c) Description 
Abundance in 
inhA1 relative 
to parent (d) 
Predicted 
signal 
sequence (e) 
8 47500412 GBAA0008 inosine 5  monophosphate dehydrogenase   + - 
92 47500503 GBAA0100 ribosomal protein L7 L12   + - 
6 47500675 GBAA0267 chaperonin GroEL   NC - 
63 47500736 GBAA0322 glutamyl tRNA Gln  amidotransferase  B subunit   NC - 
60, 77 47500760 GBAA0345 peroxiredoxin   + - 
27 47501025 GBAA0599 neutral protease Npr599   - + 
23, 42, 54, 55, 56 47501025 GBAA0599 neutral protease Npr599   + + 
9, 12 47501113 GBAA0685 conserved hypothetical protein   + + 
62 47501132 GBAA0703 Cytochrome aa3 quinol oxidase  subunit II   + + 
18, 33, 35, 38, 
39, 41, 44, 47, 95 47501230 GBAA0796 conserved hypothetical protein   + + 
89 47501230 GBAA0796 conserved hypothetical protein   NC + 
81 47501516 GBAA1094 putative wall associated protein  - + 
20 47501516 GBAA1094 putative wall associated protein  + + 
7 50082984 GBAA1191 
putative oligopeptide ABC transporter  oligopeptide 
binding protein   NC + 
4 47501617 GBAA1206 Oligoendopeptidase F   NC - 
13, 14 47501872 GBAA1449 peptidase  M23 M37 family   + + 
15 47501934 GBAA1511 glutamate dehydrogenase  NAD specific   NC - 
85 47501958 GBAA1536 putative nucleoside diphosphate kinase  - - 
65 47502136 GBAA1698 TPR glycosyl transferase domain protein   NC - 
51 47502253 GBAA1817 N acetylmuramoyl L alanine amidase  family 3   - + 
87, 90 47551689 GBAA1952 putative cell wall peptidase  NlpC P60 family   + + 
39 47502416 GBAA1973 Transcription antiterminator  LytR family   + - 
71, 75 47502674 GBAA2230 conserved hypothetical protein   + + 
30, 94 47502823 GBAA2380 alkaline serine protease  subtilase family   - + 
19 47503113 GBAA2673 chitosanase   - + 
73, 78 47503268 GBAA2827 putative chitin binding protein   - + 
64 47503268 GBAA2827 putative chitin binding protein   + + 
50 47503384 GBAA2944 Polysaccharide deacetylase   + + 
89 47503408 GBAA2967 conserved domain protein  NC + 
85 47503438 GBAA2996 RocB protein   - - 
20 47503438 GBAA2996 RocB protein   + - 
31 47503629 GBAA3189 
manganese ABC transporter  manganese binding 
protein   - + 
81 47503659 GBAA3221 Bifunctional P 450 NADPH P450 reductase 1   - - 
3 47503799 GBAA3367 LPXTG motif cell wall anchor domain protein   + + 
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Sample (a) 
Gi 
Accession (b) GBAA# (c) Description 
Abundance in 
inhA1 relative 
to parent (d) 
Predicted 
signal 
sequence (e) 
25, 26 47503992 GBAA3560 putative glycerophosphoryl diester phosphodiesterase   + + 
1 47504017 GBAA3584 putative microbial collagenase   - + 
45, 46 47551883 GBAA3588 putative lipoprotein   + + 
5 47504077 GBAA3645 
putative oligopeptide ABC transporter  oligopeptide 
binding protein   - + 
24 47504093 GBAA3660 serine protease HtrA   + - 
91 47504174 GBAA3737 surface layer N acetylmuramoyl L alanine amidase   - + 
57, 61, 66, 84 47504174 GBAA3737 surface layer N acetylmuramoyl L alanine amidase   + + 
2 47504182 GBAA3744 transketolase   + - 
94 47504280 GBAA3845 conserved domain protein  - + 
67, 69, 70, 72, 
74, 76, 79, 83, 
93, 96 47504280 GBAA3845 conserved domain protein   + + 
68 47504280 GBAA3845 conserved domain protein  NC + 
58, 59 47504400 GBAA3962 ribosome recycling factor   + - 
22 47504402 GBAA3964 translation elongation factor Ts   + - 
32 47504496 GBAA4055 penicillin binding protein   - + 
65 47504630 GBAA4187 peptide deformylase  NC - 
52 47504637 GBAA4194 
putative 2 3 4 5 tetrahydropyridine 2 carboxylate N 
succinyltransferase   - - 
48 47504637 GBAA4194 
putative 2 3 4 5 tetrahydropyridine 2 carboxylate N 
succinyltransferase   + - 
16 47504830 GBAA4387 leucine dehydrogenase   NC - 
17 47504984 GBAA4539 chaperone protein DnaK   + - 
68 47505149 GBAA4702 ATP dependent protease La 1   NC - 
34, 37, 40, 43 47505198 GBAA4750 D alanyl D alanine carboxypeptidase family protein   + + 
80 47552044 GBAA4890 thiol peroxidase   + - 
36 47505336 GBAA4893 conserved hypothetical protein   + - 
88 47505769 GBAA5312 conserved hypothetical protein   + - 
10, 11, 21, 28, 
29, 49 47552107 GBAA5427 putative cell wall endopeptidase  NlpC P60 family   + + 
82, 86 47505946 GBAA5481 conserved domain protein   + + 
53 47506179 GBAA5696 superoxide dismutase  Mn   NC - 
(a) assigned in figure 3-2. 
(b) Ames ancestor strain accession number  
(c) Ames ancestor strain associated ORF 
(d) NC – No change. +, higher in the inhA1 mutant. -, lower in the inhA1 mutant.  
(e) presence (+) or absence (-) of a signal sequence predicted using the bioinformatic 
program Signal P (46) 
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multiple differences observed in the parent and inhA1 supernates.  
 Other proteins of interest that differed in the parent and inhA1 supernates included a 
number of cell-envelope-associated proteins, indicating potential processing of cell surface 
proteins by InhA1 or InhA1-controlled proteases. Notably, putative InhA1 substrates include 
a chitinase which may be important in the soil niche of B. anthracis and enzymes associated 
with peroxide reduction which may be of significance during infection of mammalian hosts. 
Some of the inhA1-affected proteins are predicted to be cytosolic rather than secreted 
proteins, as predicted by the presence of a signal secretion sequence.  These include certain 
transcriptional regulators and chaperone proteins.  There is considerable overlap of the 
proteins that have been identified as cytosolic in the secretome analyses of B. anthracis (2, 
22).  While some of these proteins may have been released from the cell as a result of cell 
lysis others may have been exported through untraditional export mechanisms, resulting in 
the availability of these proteins as substrates for secreted proteases.  
 
Degradation of the anthrax toxin proteins is dependent upon inhA1. The anthrax toxin 
proteins, PA, LF, and EF, represent the most-well characterized secreted virulence factors of 
B. anthracis. Synthesis of these proteins is greatest when cells are cultured in media with 
dissolved bicarbonate and in the presence of elevated CO2 (51, 84).  To assess the effect of 
inhA1 on the level of the toxin proteins in culture supernates, we cultured the parent and 
inhA1 strains in toxin-inducing conditions. Supernates from exponential, transition, and 
stationary phase cultures were subjected to SDS-PAGE followed by Coomassie staining and 
Western blot analysis using PA-, LF-, and EF-specific antibodies (Fig. 3-3).  Levels of all 
three toxin proteins in the parent strain culture decreased dramatically following exponential 
phase.  However, the secreted toxin protein levels remained elevated throughout culture of 
the inhA1 mutant strain, indicating that degradation of the toxin proteins are dependent upon 
InhA1.  In contrast, the toxin protein levels in supernates of the npr599-null mutant were 
comparable to those of the parent, demonstrating that the Npr599 protease does not affect 
toxin stability.  
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Figure 3-3. Degradation of anthrax toxin proteins is dependent upon inhA1.  Parental 
strain 7702, inhA1 mutant UT345, and npr599 mutant UT317, were cultured in NBY- CO2.  
Secreted proteins were isolated and separated using SDS-PAGE.  E, exponential phase. T, 
transition phase.  S, stationary phase. (A) Coomassie blue stained gel of secreted proteins.  
The three toxin proteins (PA, EF, LF) are of a similar molecular weight at 85-90kDa.  (B) 
Western blot analysis using EF, LF, and PA-specific antibodies. 
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To further explore the relationship between InhA1 and toxin degradation, InhA1 protein 
levels in supernates of parent strain cultures were assessed at different growth phases.  The 
abundance of InhA1 increased as cultures transitioned into stationary phase, correlating with 
diminished PA levels (Fig. 3-4). Taken together, the data support a model in which secretion 
of InhA1 results in regulation of the anthrax toxin proteins in B. anthracis culture 
supernates.  
 
3.2.5. Capsule is unaffected in inhA1 mutants. Given the influence of InhA1 on the 
stability of the secreted anthrax toxin proteins, I tested for the presence of capsule, the other 
major virulence factor of B. anthracis, on cells of inhA1 and npr599 mutants. The B. 
anthracis capsule is comprised of poly-D-glutamic acid polymers and is covalently linked to 
the cell wall. Phase microscopy of india ink preparations of the capsulated Ames strain, an 
isogenic inhA1 null mutant (UTA5), and an isogenic npr599 null mutant (UTA13) revealed 
no differences in the capsulation of the cells (Fig. 3-5). 
 
3.2.6. InhA1 activity is dependent upon the zinc-binding motif.  The predicted amino 
acid sequence of InhA1 includes the conserved zinc-binding motif HEXXH at amino acids 
374-378 (HEYGH), which is characteristic of zinc-metalloproteases (28, 69). To determine 
if this sequence is associated with InhA1 activity, inhA1 mutants encoding InhA1 alleles 
with amino acid substitutions within the zinc-binding motif were constructed. As shown in 
Figure 3-6, PA degradation did not occur in a culture supernate of a H374A mutant; PA 
levels were comparable to those observed in the supernate of an inhA1-null strain. 
Moreover, the secretome profile of the H374A mutant was comparable to that of the inhA-
null strain (Fig. 3-1A). The phenotypes of additional mutants harboring amino acid 
substitutions in the zinc-binding motif also displayed the inhA1-null phenotype (Fig. 3-1A).  
Interestingly, the H374A and E375A InhA1 proteins migrated more slowly than the native 
InhA1 protein in SDS-PAGE (Fig 3-1A and 3-1B), suggesting a possible cleavage event is 
necessary for activity.  N-terminal sequencing and mass spectrometry analysis of bands 
reacting with anti-InhA1 antibody (Fig. 3-1B), confirmed their identity.  N-terminal 
sequencing of the H374A protein confirmed cleavage of the predicted signal peptide,  
 39 
 
Figure 3-4. Abundance of PA in the supernatant is inversely correlated with the 
abundance of InhA1.  Temporal analysis of PA and InhA1 in B. anthracis culture 
supernatants after culturing in NBY- CO2 as assessed using Western blot analysis with PA 
and InhA1-specific antibodies.  E, exponential phase. T, transition phase.  S, stationary 
phase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 40 
 
Figure 3-5. Capsule is unaffected by InhA1 or Npr599.  Qualitative analysis of capsule 
produced by the parent (Ames), inhA1 (UTA5), and npr599 (UTA13) mutant strains as 
assessed using India ink exclusion assay. 
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Figure 3-6. InhA1 activity is dependent on a conserved zinc binding motif.  Western blot 
analysis of PA abundance in the culture supernatant of parental strain 7702, inhA1 null 
mutant UT345, and the H374A inhA1 zinc-binding motif mutant strain UT368.  The sequence 
of the zinc binding motif is shown for each strain.  E, exponential phase. T, transition phase.  
S, stationary phase. 
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MNKKPFKVLSSIALTAVL GLSFGAGGQSVYA31, from the full length (795 amino acids) 
protein.  Other mutants, H374D/E375A, E375A/H378D, and H378A did not accumulate in 
their culture supernates or with in the cell (Fig. 3-1), suggesting that the mutations adversely 
affected stability of the protease.  The instability of the H374D/E375A, E375A/H378D, and 
H378A mutant strains and the lack of activity of the H374 and E375A mutant strains 
suggests that the zinc-binding motif and the availability of zinc ions are important in the 
regulation of InhA1. 
 
3.2.7. Purification of InhA1. Attempts to purify InhA1 from B. anthracis Ames cured of 
pXO1 and pXO2 using methods established previously (28) resulted in impure preparations 
that contained the camelysin protease and the S-layer protein Sap (data not shown). 
Camelysin has been implicated in degradation of InhA1 in culture supernates (Chapter IV).  
To eliminate these problems, I created a B. anthracis strain deficient in secretion of these 
proteins.  The recombinant strain, UT357, is deleted for the camelysin gene, calY, and 
carries a mutation in the secA gene which prevents Sap secretion but does not affect protease 
secretion [Colin Harwood, personal communication].  InhA1 was purified from stationary-
phase culture supernates of the calY secA mutant using anion exchange chromatography.  
Protein purity was assessed using SDS-PAGE with Coomassie staining, Western 
hybridization analysis, and mass spectrometry. Repeated purification attempts resulted in 
preparations containing proteins of non-uniform size (Fig. 3-7). The major proteins with 
apparent masses of 75- and 42-kD constituted bulk of the protein in the sample. These 
correspond to the full length and active forms of the protein as reported previously by Chung 
and coworkers (28). The re-occurring appearance of InhA1 species with specific molecular 
weights suggests that InhA1 is similar to other secreted proteases in that it processed prior to 
activation in a reaction that is hypothesized to be auto-proteolytic in nature (64, 157).  
Results of mass spectrometry analysis of the purified protein sample indicated a pure InhA1 
preparation, as all protein fragments observed corresponded to InhA1 amino acid sequences.   
 
3.2.8. InhA1 directly cleaves the B. anthracis toxin proteins and neutral protease.  Our 
data from DIGE analysis of parent and inhA1-null strains reveal that inhA1 affects the
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Figure 3-7. Purification of InhA1 from B. anthracis culture supernate.  Purified InhA1 
protein was separated using SDS-PAGE and the gel stained with Coomassie Blue.  Bands 
highlighted with asterisks correspond to the molecular weights of previously identified 
InhA1 protein isoforms (28). 
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stability of at least eight other proteases (Table 3-1). Therefore, the global affects of InhA1 
on the secretome may be attributed in part to downstream effects of one or more proteases 
targeted by InhA1.  To assess whether InhA1 directly or indirectly cleaves PA, EF, LF, and 
Npr599 proteins we performed in vitro protease assays.  Purified InhA1 was incubated with 
rPA, rLF, rEF, rNpr599, or rSODA-1, a super oxide dismutase of B. anthracis utilized as a 
negative control. Following incubation at 37oC, samples were subjected to Western 
hybridization using antisera against the potential substrates. The toxin proteins and Npr599 
were all degraded by InhA1, but susceptibilities to protease activity varied (Fig. 3-8).  
Distinct PA fragments with apparent masses of 54 and 43kDa were detected immediately 
upon contact with InhA1 and PA was fully degraded following extended incubation. In 
contrast, processing of EF, LF, and Npr599 did not reveal abundant distinct cleavage 
products, rather the majority of protein became undetectable after prolonged incubation.  
Equivalent substrate:enzyme ratios and times of incubation did not result in degradation of 
the SodA-1 protein.  
 The amino terminal sequences of the distinct PA protein fragments were determined 
using amino-terminal sequencing. The amino-terminal sequences of the bands indicated in 
Fig. 3-8A, NRLLNESESS, VHASFFDI, and APIALNAQDD, indicate that InhA1-mediated 
cleavage of the secreted form of the PA (735-amino acid) protein occurred after residues 5, 
308, and 416. It is notable that the resulting protein fragments do not correspond to the 
cleavage site at residue 167 which is associated with processing required for toxin entry into 
eukaryotic cells (82, 105). 
 The amino terminal sequence of the minor cleavage product of EF (Fig. 3-8A), 
GVEKDRI, indicated InhA1-cleavage of the EF protein between residues 287 and 288. As 
incubation of rLF and rNpr599 with InhA1 did not result in consistent protease reaction 
products cleavage sites were not determined for these substrates. Taken together, my data do 
not reveal a specific amino acid sequence associated with processing by InhA1. 
Nevertheless, InhA1 directly processes the three toxin proteins and the Npr599 protease with 
varying degrees of specificity. 
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Figure 3-8. InhA1 directly cleaves the anthrax toxin proteins and protease Npr599.  
Purified InhA1 was incubated with rPA, rLF, rEF, rNpr599, or rSodA-1.  Reactions were 
separated using SDS-PAGE and subjected to Western blot analysis.  (A) Western analysis 
using PA, LF, and EF-specific antibodies.  Bands submitted for amino-terminal sequencing 
are highlighted with asterisks.  Amino-terminal sequences identified were VHASFFDI (PA, 
54kDa band), NRLLNESESS and APIALNAQDD (PA, 43kDa band), and GVEKDRI (EF 
band). (B) Western analysis using Npr599-specific antibodies.  (C) Western analysis using 
SodA-1 specific antibodies. 
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3.3. Discussion 
 Using DIGE to analyze the secretome of B. anthracis it was established that InhA1, 
either directly or indirectly, modified the abundance of more than half of the proteins found 
in the culture supernate.  While only 96 (of the 1,340 protein spots) of the most abundant 
protein spots were identified, this analysis uncovered that substrates from multiple 
functional categories were affected by InhA1, including putative immunomodulatory 
proteins and proteins involved in nutrient acquisition.  The largest functional group 
identified from the proteomic analysis was proteins with proteolytic activity, including 
Npr599.  While the focus of the study was to assess the contribution of InhA1 in the 
modulation of the secretome, a number of cell associated proteins were also identified as 
being InhA1-regulated, which implicates InhA1 in affecting how B. anthracis interacts with 
its environment.   
 In B. anthracis, proteases constitute a considerable fraction of the secretome.  InhA1 
and Npr599 are the most abundant proteins in the culture supernatant (22).  Purified Npr599 
has some substrate overlap with InhA1 with respect to host substrates.  Like InhA1, Npr599 
cleaves ECM proteins collagen and fibronectin, however Npr599 is less active against 
proteins of the coagulation cascade than InhA1 (28).  Cleavage of the ECM components 
collagen and fibronectin by B. anthracis proteases may inhibit colonization of host tissues.  
Since both InhA1 and Npr599 cleave collagen and fibronectin it is unclear whether B. 
anthracis adherence would be modified as a consequence of Npr599 cleavage by InhA1. 
Given the abundance of Npr599 in in vitro cultures, the inactivation of this protein would be 
hypothesized to have significant effects on the composition of extracellular proteins, of both 
host and bacterial origin.   
 The activity of secreted proteases is regulated post-translationally by several 
processing events, first by a signal peptidase upon secretion, then often by an auto-cleavage 
event that precedes activation (64, 147, 157).  However, protease activity can also be 
regulated through a proteolytic cascade, allowing for the various proteases secreted by a 
bacterium to regulate the activity of other proteases (134); my data suggest that such a 
cascade is used by B. anthracis to regulate the timing of specific protease activity.  An early 
step in the putative regulatory cascade is production of the cell-envelope-associated protease 
camelysin, which is implicated in degrading InhA1 in the supernatant during early stationary 
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phase (see Chapter IV).  As the cells progress through stationary phase InhA1 increases in 
abundance (see Chapter IV).  Increased InhA1 activity leads to the processing of at least 
nine other proteases present in B. anthracis culture supernatants, including the direct 
processing of Npr599 and LF.  A possible benefit that a protease cascade may confer upon 
B. anthracis is the amplification of the number of extracellular substrates susceptible to 
proteolysis by active proteases.  In addition, each of the proteases available for activation are 
likely regulated transcriptionally in response to independent environmental or growth phase 
signals, thereby amplifying the number of input signals into the regulatory cascade.  
Furthermore, a protease-based regulatory mechanism would allow for the post-translational 
regulation of the proteins in the secretome, regulation that may be necessary when rapid 
change of protein activity is necessary.  Such regulation could be important in response to 
changing signals or tissue type as the cell disseminates through the host.  The presence of a 
proteolytic regulatory cascade is not without precedent; such a phenomenon has been 
described in Staphylococcus aureus for the regulation of extracellular proteases SspA, SspB, 
and Aur. (134).   
 The activity of the toxin protein PA is regulated in response to physiological 
conditions in the host (89, 115).  PA binds host cell receptors ANTXR1 and ANTXR2 and 
subsequently forms a heptameric ring on the cell surface creating binding sites for EF and/or 
LF prior to endocytosis (158).  The heptameric form of PA undergoes a change in 
conformation upon acidification of the endosome, allowing for the translocation of EF and 
LF into the cytosol (89, 158).  In addition, PA undergoes a loss in activity due to prolonged 
exposure to elevated temperatures (37ºC) (115).  Here I report an additional regulatory 
mechanism that results in differentiated toxin protein accumulation in response to growth 
phase.  InhA1 accumulates in the culture supernates during the transition and stationary 
phases of growth and cleaves PA within the protease accessible unstructured loops of 
domain 2 (112).  Domain 2 contains critical residues involved in anthrax toxin pore 
formation and links the receptor binding activity of the C-terminal domain 4 to the EF/LF 
binding sites within domain-1 (89).  Cleavage of PA following resides E308 and L416 by 
InhA1 would disassociate the receptor and EF/LF binding subunits and may alter the 
confirmation of the protein allowing for increased protease susceptibility and degradation.  
Furthermore structural analysis of PA indicates that the InhA1 cleavage sites are likely to 
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only be accessible when PA is in its monomeric form (89, 112), suggestive of InhA1 acting 
on PA prior to host cell binding.  
 Degradation of the toxin proteins by InhA1 may significantly alter virulence.  
Degradation may reduce development of neutralizing antibodies against these proteins in the 
infected host.  Alternatively, the timing of toxin accumulation may be important during 
infection, and InhA1 may facilitate this by keeping toxin protein concentration low during 
certain stages of infection or in a specific tissue or cell type.  Interestingly, the accumulation 
of toxin in the host prior to the patient becoming septic is necessary for full dissemination 
(96), indicating a need for temporal regulation of the toxin proteins.  It should be noted that 
the processing of toxins in the extracellular milieu is not a mechanism unique to B. 
anthracis.  SpeB, a protease secreted by Streptococcus pyogenes, limits the concentration of 
multiple other virulence factors in a growth-phase dependent manner (107), and is 
hypothesized to be important in reducing the presentation of antigens during upper 
respiratory tract infection (143).  In addition to limiting the abundance or activity of toxins 
via degradation, proteases secreted by pathogens have also been found to activate toxins, as 
in the case of the Vibrio cholerae protease HA which activates the A subunit of cholera 
toxin (10).  To date I have no evidence of protein activation by InhA1 cleavage.   
 InhA1 is responsible for the cleavage of a wide array of bacterial and host substrates; 
however the protease did not alter the concentration of every protein in the culture 
supernate, indicating that InhA1 does have a level of substrate specificity, albeit a limited 
one.  This was confirmed through my in vitro proteolytic assays using purified InhA1, 
establishing that InhA1 directly cleaves the anthrax toxin proteins and Npr599, but not the 
superoxide dismutase, SodA-1.  The rapid cleavage of PA resulting in distinct products 
indicates that proteolysis by InhA1 is specific.  However, as my purified InhA1 preparation 
contained multiple forms of InhA1, many of which may have been inactive, it was not 
possible to determine the specific activity of the protein.  It was noted that higher 
concentrations of InhA1 were necessary to degrade the toxin proteins than Npr599.  The 
seemingly higher affinity of InhA1 for Npr599 may highlight the importance of the protease 
cascade in B. anthracis.   
The vast affects on the secretome of B. anthracis attributed to InhA1, due to the 
apparent low substrate cleavage specificity, suggests that the spatial and temporal regulation 
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of protease activity is crucial to minimize deleterious effects due to InhA1 activity.  Spatial 
regulation of InhA1 activity is in part accomplished through the presence of a secretion 
signal sequence at the N-terminus of the proenzyme which marks the protein for secretion 
(147).  In its environment the availability of metal ions may limit the activity of InhA1(102).  
Temporal regulation of InhA1 activity occurs through mechanisms that include: (i) 
proteolytic inactivation of InhA1 function by other secreted proteases (such as camelysin 
[see Chapter IV]), and (ii) regulation at the transcript level by the SinI/R regulatory proteins 
(see Chapter IV).   
 In addition to a potential role for InhA1 in virulence my data also predict a role for 
survival in the soil.  As the promoter for inhA1 is active in B. anthracis when cultured in the 
soil (126), it is posited that InhA1 is available to regulate environmentally-significant 
proteins.  Examples of environmentally-significant proteins affected by InhA1 are chitin 
associated proteins.  The abundance of a chitinase and chitin-binding protein were each 
found to be regulated differentially in the culture supernatant of the parent and inhA1 mutant 
strains.  Chitinases and chitin-binding proteins are utilized by bacteria to breakdown the 
cell-wall of fungi or the chitin produced by insects in the soil (151).  By modulating proteins 
in the environment InhA1 may regulate nutrient acquisition and prolong survival of the 
bacteria or accelerate the progression into sporulation (see Chapter V). 
 The modulation of the B. anthracis secretome by InhA1 may have a multitude of 
downstream effects, from enhancement of cell survival to increased virulence.  Here I have 
shown that InhA1 can act directly or indirectly to post-translationally regulate extracellular 
proteins.  Modulation of toxin protein levels in vitro implicates InhA1 as a post-translational 
regulator of toxin in the host, potentially directing the timing of toxin protein accumulation.  
This is the first bacterial protease identified to cleave the anthrax toxin proteins.  The post-
translational regulation of toxin proteins in response to growth phase adds an additional 
layer of regulation to toxin production, complementing the well-established regulation of 
toxin gene transcription by the pleiotropic virulence protein regulator AtxA in response to 
bicarbonate and elevated CO2 (51, 84).  By maintaining the abundance of proteins in the 
culture supernate via a proteolytic cascade the number of proteins regulated is amplified, 
providing the opportunity to fine-tune the composition of proteins in the extra-cellular 
 50 
milieu through integration of multiple independent extra-cellular signals.  Signaling could be 
direct, in terms of co-factors available in the environment (e.g. metal ion availability), or 
indirect through a plethora of transcriptional and post-transcriptional regulatory systems.   
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Chapter IV 
The Bacillus anthracis sin locus 
and regulation of secreted proteases 
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4.1. Introduction 
 Bacillus species are developmental bacteria that cycle between a dormant spore state 
and a metabolically active vegetative cell state. Vegetative cells can grow as planktonic cells 
or in multicellular biofilms. Environmental cues affect cellular and community 
morphologies via complex regulatory systems that are generally conserved throughout the 
genus. One such system is the pleiotropic SinI/R regulatory pair. The sin locus (sporulation 
inhibitor) was originally described in B. subtilis as a component of the sporulation cascade 
(55). Subsequent studies revealed that in addition to negatively regulating several genes 
involved in sporulation, SinR also regulates motility, competency, proteolysis, and biofilm 
formation genes in B. subtilis (7, 24, 25, 62, 78, 83, 88, 94, 100, 152).  The SinR protein 
binds a conserved DNA sequence upstream of the translational start site of target genes to 
either positively or negatively control transcription. SinI, encoded by a gene adjacent to 
sinR, is a SinR antagonist and binds directly to the SinR protein to inhibit its activity (5).  In 
batch culture, SinR is expressed throughout growth, while SinI expression is limited to 
stationary phase (54, 133). Thus, SinR-controlled gene expression is relieved when cultures 
transition from exponential to stationary phase.   
While SinI/R function and the sin regulon are well established in B. subtilis, there are 
few reports concerning the SinI/R regulatory system in other Bacillus species. B. anthracis, 
the etiological agent of anthrax, has a sinI/R locus, but is devoid of multiple characteristics 
associated with SinI/R function in B. subtilis. Unlike B. subtilis, B. anthracis is non-motile, 
does not produce naturally competent cells, and does not readily produce biofilms (14, 101, 
128). Although known and potential virulence factors of B. anthracis have been shown to be 
produced in a growth-phase-dependent manner, there are no reports of control of these 
factors by SinI/R during growth in batch culture. One study indicates that in B. 
thuringiensis, an insect pathogen closely related to B. anthracis (40, 138, 150), the SinI/R 
system controls expression of the immune inhibitor A1 gene inhA1; overexpression of sinR 
in B. thuringiensis results in decreased expression of inhA1, while overexpression of sinI 
results in elevated inhA1 transcript levels (58). Immune inhibitor A1 is a secreted 
metalloprotease that degrades insect antimicrobial peptides and enhances the ability of B. 
thuringiensis to escape from macrophages (116). B. anthracis also produces an InhA1 
protease that has been implicated as having a role in virulence. The B. anthracis protease 
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may directly affect virulence by cleaving the host proteins von Willebrand Factor and pro-
thrombin, proteins associated with the coagulation cascade, as well as several extracellular 
matrix proteins (26-28, 79, 116). Indirectly, InhA1 may affect virulence by degrading 
proteins secreted by B. anthracis, including the anthrax toxin proteins (see Chapter III).  
SinI/R control of B. anthracis inhA1 gene expression has not been reported.  
 In work described here, the role of the SinI/R system in B. anthracis was examined 
using genome-wide expression microarray and immunoblot analyses to assess 
transcriptional and post-translational regulation of SinR/I-regulated genes.  I show that in 
addition to homologues of some B. subtilis SinR-regulated genes, the B. anthracis SinR 
negatively regulates transcription of genes adjacent to the sinI/R locus that are unique to the 
B. cereus group species (B. anthracis, B. cereus, and B. thuringiensis). My data show that 
InhA1 protease levels are regulated at the transcriptional level by the SinI/R system and at 
the post-translational level by a second SinR-regulated protease, camelysin. 
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4.2. Results 
4.2.1. Comparison of sin loci. In B. subtilis, the sinI and sinR genes are adjacent to each 
other on the chromosome and are cotranscribed (133). The sinI/R genes of B. anthracis are 
aligned similarly and are likewise hypothesized to be co-transcribed. The amino acid 
sequences of the SinR proteins are 67% identical, with conserved residues spanning the 
length of the proteins. Eighteen of 20 conserved residues in the B. subtilis SinR helix-turn-
helix motif are identical to those of the B. anthracis SinR, and the two non-conserved 
residues represent conservative substitutions. In addition, the region of SinR that is predicted 
to interact with SinI (92) is moderately conserved; 21 of 29 residues are identical in the SinR 
proteins of the two species. The B. subtilis and B. anthracis SinI proteins are conserved to a 
lesser degree, exhibiting 42% identity and 76% similarity throughout the middle of the 
proteins, the residues of SinI that interact with SinR (92). The N- and C-termini are not 
conserved. 
There are notable differences between B. subtilis and B. anthracis with regard to 
sequences adjacent to sinI/R (Fig. 4-1). One target of the B. subtilis SinI/R regulatory 
system, the tricistronic operon comprised of yqxM, sipW, and tasA, is located immediately 
downstream of the B. subtilis sin operon in the opposite orientation. The yqxM/sipW/tasA 
operon is associated with biofilm formation by B. subtilis (24). The yqxM gene encodes a 
lipoprotein, while sipW encodes a signal peptidase, and tasA encodes a biofilm matrix 
protein.  B. anthracis lacks the yqxM gene and although the tandem sipW and tasA genes are 
present, they are separated from sinI/R by two open reading frames (ORFs), GBAA1289 and 
GBAA1290, that are absent in B. subtilis. GBAA1289 is annotated as containing a nonsense 
mutation, and is therefore considered to be a pseudo-gene.  ORF1290 has been designated 
calY because the ORF is predicted to encode a protein with an amino acid sequence that is 
greater than 90% identical to the calY-encoded protein, camelysin, of B. cereus ((59) and 
NCBI blast). B. cereus camelysin is a protease that is cell-envelope associated (59). 
Sequences upstream of sinI/R also differ between B. subtilis and B. anthracis. In B. 
anthracis, inhA1, encoding the freely-secreted InhA1 protease, is located upstream of sinI 
and in the opposite orientation (Fig. 4-1). In B. subtilis, yqhG lies 977-bp upstream of sinI in 
the same orientation; the inhA1 gene is not present.  An orthologue of yqhG (GBAA4451), 
which encodes a conserved hypothetical protein, is present on the chromosome of 
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Figure 4-1. Schematic representation of the sin loci of B. subtilis and B. anthracis.  Orfs 
are represented by block arrows facing the direction of transcription.  Conserved genes are 
color coded. 
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B. anthracis at a distant locus. Analysis of the available genome sequences of species 
closely related to B. anthracis, B. cereus and B. thuringiensis, indicates that the extended sin 
loci in these species match that of B. anthracis. 
 
4.2.2. Assessment of the SinR regulon in B. anthracis. Differences in sinI/R-associated 
phenotypes of B. subtilis and B. anthracis, and structural dissimilarities in the sin loci, 
suggest disparities in the SinR regulons of the two species. To determine the SinR regulon 
of B. anthracis genome-wide transcriptional profiling experiments were conducted 
comparing the fully virulent Ames strain to an isogenic sinR-null mutant, UTA21.  
Transcript levels at exponential and stationary phases of growth were compared (Fig. 4-2A). 
The data identified that the expression of 41 genes differed between the parent and sinR 
mutant strains.  Note that for a gene to be designated as SinR-regulated in my study it 
required a two-fold or greater difference in regulation between the parent and sinR mutant 
strain as assessed by three independent data analysis programs (Tables 4-1 and 4-2; see 
chapter 2 section 5).  Regulation by SinR was growth phase-dependent in all cases except 
GBAA1287 (sipW), GBAA1288 (tasA), GBAA1290 (calY), and GBAA1075 
(exonuclease/exonuclease phosphotase) (Fig. 4-2A, and Tables 4-1 and 4-2). All genes that 
displayed differential regulation during exponential growth were negatively regulated by 
SinR. 
 The most highly regulated genes were located within the greater sin locus.  The calY, 
sipW and tasA gene transcript levels were elevated 140-, 50-, and 58-fold respectively, in the 
sinR mutant strain indicating negative regulation by SinR. Note that probes representing 
gene GBAA1289, annotated as a pseudo-gene, were not represented in the array. In contrast 
to the genes 3’ of sinI/R, expression of the upstream gene inhA1 was elevated only 2.9-fold 
in the sinR mutant. Moreover, the difference in inhA1 expression was only observed using 
RNA from exponential phase cultures, unlike the differences in calY, sipW and tasA 
expression which were apparent at exponential and stationary phases (Tables 4-1 and 4-2). 
The three most highly sinR-regulated genes outside of the expanded sin locus, GBAA1075 
(exonuclease/exonuclease phosphotase), GBAA3645 (oligopeptide-binding protein oppA), 
and GBAA5262 (hypothetical exported repetitive protein), were negatively regulated 5-, 6-, 
and 8-fold, respectively (Tables 4-1 and 4-2).  
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Figure 4-2. SinR-controlled transcriptome of B. anthracis.  (A.) Scatter plot of ORFs 
differentially regulated in sinR mutant strain (UTA21) relative to the parent strain (Ames) as 
determined using expression microarray analysis. Data presented as log2 fold-change. The 
color of the gene in the schematic below the scatter plot corresponds to the data point.  
Below the schematic are the average growth of the parent (Ames) and sinR mutant strain 
(UTA21).  +/- standard deviation are shown.  Arrows highlight the two time points analyzed 
using expression microarray analysis. (B.) sinR-regulated genes during exponential growth 
phase grouped by annotated function. (C.) sinR-regulated genes during stationary growth 
phase grouped by annotated function. 
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Table 4-1.  SinR-regulated genes in B. anthracis during the exponential phase of growth. 
Gene (a) Annotation (b) 
d-chip 
fold- 
change 
Excel 
fold- 
change 
Array 
star fold- 
change Ba consensus (c) 
Bs 
homologue (d) 
GBAA0031 Methyltransferase (EC 2.1.1.-) 2.49 2.21       
GBAA0032 
Hypothetical protein with endo 
excinuclease domain 2.51 2.49       
GBAA0597 Transcriptional activator NprR   3.58 2.48     
GBAA0908 
Oligopeptide-binding protein 
oppA 2.4 2.15       
GBAA0992 
RNA polymerase sigma-B 
factor 2.18 2.21       
GBAA1075 
Endonuclease Exonuclease 
phosphatase family protein 7.99 5 4.77 GTTATAA (-38) N/A 
GBAA1095 Hypothetical protein   2.89 2.1     
GBAA1166 yajQ 2.25 2.28       
GBAA1278 Hypothetical protein 2.11 2.1       
GBAA1284 Hypothetical protein 2.26 2.15       
GBAA1287 
Signal peptidase I (EC 
3.4.21.89) sipW 3.8 50 7.55 
GTTATAA (-50)  
GTTATAT (-91) sipW 
GBAA1288 tasA 9.5 58.82 11.98   tasA 
GBAA1290 calY 63.89 142.86 121.49 
ATTCTCT (-63) 
GTTATAT (-69) 
GTTATAA (-120) N/A 
GBAA1292 sinR -28.34 -48.43 -21.8 GTTCTTT (-76)  sinR 
GBAA1295 inhA1 1.99 2.92 2.17 
GTTATAA (-66)* 
GTTATAA (-77)* N/A 
GBAA1583 
Cell division initiation protein 
DivIVA 2.33 3.08       
GBAA1959 Hypothetical protein   2.98 2.15     
GBAA2041 
Oligopeptide-binding protein 
oppA 2.14 2.65       
GBAA2199 Hypothetical protein   3.64 2.32     
GBAA2399 Zn-dependent hydrolase 4.25 2.85       
GBAA2525 Hypothetical cytosolic protein 2.63 3.14       
GBAA3140 UvrC-like protein   3.95 2.21     
GBAA3146 Hypothetical protein 2.2 2.59       
GBAA3305 
Transcriptional repressor 
pagR-like 3.27 3.22 2.04 
GTTGTGT (-45) 
ATTATGT (-61) 
GTTATGT (-123) N/A 
GBAA3645 
Oligopeptide-binding protein 
oppA 5.87 5.95 3.52 
ATTATAT (-
189)* oppA 
GBAA3647 
Transcriptional regulator, LytR 
family 2.65 2.04       
GBAA3829 
Phage transcriptional regulator, 
Cro CI family   5.68 2.34     
GBAA3830 Phage-related protein   3.56 2.39     
GBAA3845 
SH3 domain protein   3D 
domain protein 3.73 2.15       
GBAA4162 GTPase 2.08 2.24       
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GBAA4195 
Transcriptional regulators, 
LysR family 3.56 3.31       
GBAA4197 Hypothetical protein 2.55 2.32       
GBAA4342 Hypothetical protein 6.3 5.41       
GBAA_pX01_101 Hypothetical protein 3.71 4       
GBAA_pX01_146 Transcriptional regulator atxA 2.44 3.28       
GBAA_pX01_199 
GTP pyrophosphokinase (EC 
2.7.6.5) 3.04 2.54       
(a) Ames ancestor strain annotated ORF  
(b) Ames ancestor strain annotated description 
(c) Putative B. anthracis SinR binding site of SinR-regulated genes (nucleotides upstream of 
the ATG).  The asterisks indicate an inverted sequence and the number in parentheses notes 
the base pairs upstream of the translational start.   
(d) B. subtilis homologue of B. anthracis SinR-regulated gene 
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Table 4-2. SinR-regulated genes in B. anthracis during the stationary phase of growth. 
Gene (a) Annotation (b) 
d-chip 
fold- 
change 
Excel 
fold- 
change 
Array 
star fold- 
change Ba consensus (c) 
Bs 
homologue (d) 
GBAA0061 
Stage II sporulation protein E 
(EC 3.1.3.16) 2.60 2.24 2.39 ATTCTTA (-115) spoIIE  
GBAA0229 Hypothetical protein 3.74 2.02 3.04 ATTCTCT (-55) N/A 
GBAA0270 
Guanine-hypoxanthine 
permease   -3.83 -2.31     
GBAA0288 Pure   -5.42 -2.87     
GBAA0289 purK   -2.90 -5.06     
GBAA0290 purB   -2.15 -2.78     
GBAA0291 purC   -3.29 -4.56     
GBAA0292 purS   -3.43 -5.31     
GBAA0293 purQ   -2.85 -4.58     
GBAA0294 Purl   -2.53 -4.78     
GBAA0295 purF   -2.61 -3.59     
GBAA0296 purM   -2.18 -6.24     
GBAA0297 purN   -2.21 -3.22     
GBAA0573 
Hypothetical membrane 
spanning protein 4.06 3.79 5.29 GTTATTT (-71) N/A 
GBAA0574 Hyptothetical protein 11.37   9.09     
GBAA0977 Hyptothetical protein 3.44 2.05 2.69 GTTATAA (-31) N/A 
GBAA1020 Hyptothetical protein 2.84 2.06       
GBAA1075 
Endonuclease Exonuclease 
phosphatase family protein 3.69 2.85 2.94 GTTATAA (-38) N/A 
GBAA1287 
Signal peptidase I (EC 
3.4.21.89) sipW 10.89 16.95 19.07 
GTTATAA (-50)  
GTTATAT (-91) sipW 
GBAA1288 tasA 10.17 9.62 13.86   tasA 
GBAA1290 calY 4.29 4.35 8.08 
ATTCTCT (-63) 
GTTATAT (-69) 
GTTATAA (-120) N/A 
GBAA1292 sinR -47.78 -50.12 -27.11 GTTCTTT (-76)  sinR 
GBAA1481 
DNA integration 
recombination inversion 
protein 3.40 3.76 4.02 
ATTCTGT (-
106)* GTTGTAT 
(-153) xerD  
GBAA1530 Stage IV sporulation protein A 2.54 2.02       
GBAA1577 Hypothetical protein 2.25 2.26 2.41 GTTCTTT (-200) N/A 
GBAA1578 Hypothetical protein 1.83 2.21       
GBAA1591 Xpt   -6.41 -3.00     
GBAA1592 pbuX   -5.14 -2.38     
GBAA1756 
Cobalt-zinc-cadmium 
resistance protein czcD 1.98 2.21 2.10 GTTCTTT (-253) czcD 
GBAA2083 
Macrolide glycosyltransferase 
(EC 2.4.1.-) 3.20 2.39 2.29 ATTATAT (-27) yojK 
GBAA2152 Hypothetical protein 2.34 2.27 2.01 
GTTATAA (-
173)* GTTATAA 
(-242) yvcN 
GBAA2287 polar chromosome segregation 2.35 2.71 2.36 ATTCTTT (-129) racA 
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GBAA2521 
Response regulator aspartate 
phosphatase inhibitor 2.14   2.15     
GBAA2619 Hypothetical protein   3.14 2.59     
GBAA2770 Hypothetical protein   -2.09 -2.34     
GBAA2771 Hypothetical protein -2.03 -1.90 -2.24 GTTATTT (-37)* N/A 
GBAA2773 
Dihydrolipoamide 
dehydrogenase (EC 1.8.1.4) 
acoL -2.24 -2.31 -2.61   acoL  
GBAA2774 
Dihydrolipoamide 
acetyltransferase component 
of acetoin dehydrogenase 
complex (EC 2.3.1.-) acoC -2.24 -2.42 -3.02   acoC  
GBAA2775 
Acetoin dehydrogenase E1 
component beta-subunit (EC 
1.2.4.-)  acoC -2.31 -2.53 -2.96   acoB  
GBAA2776 
Acetoin dehydrogenase E1 
component alpha-subunit (EC 
1.2.4.-)  acoA -2.38 -2.42 -2.30 ATTCTCA (-173)  acoA  
GBAA2853 Cell division protein divIC 3.29 3.04 2.64 
ATTGTGT (-21)* 
GTTATTT (-302)* divIC 
GBAA2982 
Fructose-bisphosphate 
aldolase (EC 4.1.2.13) 3.21 2.00       
GBAA3834 
Transcriptional regulator 
glnR, MerR family -1.99 -2.01 -2.02 
ATTGTGA (-
218)* glnR  
GBAA3844 Hypothetical protein 3.07   3.20     
GBAA4043 
RNA polymerase sigma-E 
factor 2.48 2.76 2.95 GTTATGT (-71)* sigE  
GBAA4044 
Sporulation sigma-E factor 
processing peptidase (EC 
3.4.23.-) 2.48 2.21 2.18 ATTATGT (-101)  spoIIGA 
GBAA4202 Hypothetical protein 2.43 2.42 2.36 
ATTCTTT (-17)* 
ATTGTTA (-54) 
GTTGTAA (-100) N/A 
GBAA4222 Hypothetical cytosolic protein 2.40 2.74 2.58 ATTCTTT (-69) N/A 
GBAA4342 Hypothetical protein 2.46 2.31 2.64 GTTCTGT (-197) N/A 
GBAA4410 
Stage III sporulation protein 
AH 2.92 2.02 2.55   spoIIIAH  
GBAA4411 
Stage III sporulation protein 
AG 3.30 2.67 2.78   spoIIIAG 
GBAA4412 
Stage III sporulation protein 
AF   2.03 2.40 
GTTATTA (-52)*  
GTTGTTT (-161)*   
GBAA4572 
GTP pyrophosphokinase (EC 
2.7.6.5) 2.37 2.47       
GBAA4657 
Hypothetical membrane 
spanning protein -2.07 -2.21       
GBAA4712 Hypothetical protein -2.57   -2.20     
GBAA5210 Hypothetical protein -2.33   -2.01     
GBAA5262 
Hypothetical exported 
repetitive protein 9.65 8.00 6.53 ATTGTAT (-52) N/A 
GBAA5523 Hypothetical protein 2.36 2.42 2.40 ATTATAT (-32)* N/A 
GBAA5524 SpoIIQ   -2.28 -2.06     
GBAA5633 
Prespore specific 
transcriptional activator rsfA 2.42 2.56 2.48 
ATTGTTA (-70) 
ATTGTAA (-131) rsfA 
GBAA5640 
Spore cortex lytic enzyme 
cwlJ   2.08 2.10     
GBAA_pX02_0017 Hypothetical protein -4.04 -2.75 -2.29   N/A 
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GBAA_pX02_0019 Hypothetical protein -4.57 -3.02 -3.34   N/A 
GBAA_pX02_0020 Hypothetical protein -3.95 -3.00 -2.18   N/A 
GBAA_pX02_0021 Hypothetical protein -4.49 -3.01 -2.42   N/A 
GBAA_pX02_0023 
Putative Type IV secretion 
system component -3.94 -3.35 -2.52   N/A 
GBAA_pX02_0024 Hypothetical protein   -2.48 -2.15   N/A 
GBAA_pX02_0025 Hypothetical protein  -3.66 -4.78 -2.21   N/A 
GBAA_pX02_0026 Hypothetical protein   -1.85 -2.13 
GTTGTTT (-24)*  
ATTCTTT (-87)* N/A 
(a) Ames ancestor strain annotated ORF  
(b) Ames ancestor strain annotated description 
(c) Putative B. anthracis SinR binding site of SinR-regulated genes (nucleotides upstream of 
the ATG).  The asterisks indicate an inverted sequence and the number in parentheses notes 
the base pairs upstream of the translational start.   
(d) B. subtilis homologue of B. anthracis SinR-regulated gene 
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 The majority of SinR-regulated genes were located on the chromosome, however a 
putative 26-gene operon on pX02 virulence plasmid, starting with GBAA_pX02_0028, was 
positively regulated by SinR during stationary phase growth.  I note that not all of the genes 
of the putative operon were found in my analysis.  While the genes in the operon are largely 
annotated as conserved hypotheticals, GBAA_pXO2_0023 is annotated as encoding a type 
IV secretion system protein (61, 118).  B. subtilis does not carry homologues of the pXO2 
SinR-regulated genes.   
The SinR-regulated genes of B. anthracis are grouped according to annotated 
function in figures 4-2B and 4-2C.  Only seven genes were identified as SinR-regulated  
during the exponential phase of growth, with the largest class of genes annotated as 
encoding proteins with degradative properties, including the secreted protease genes inhA1 
and calY, sipW, and the nuclease-encoding gene GBAA1075 (Fig. 4-2B and Table 4-1). 
Additional genes regulated by SinR during exponential growth phase include a regulatory 
gene (GBAA3305), and two genes that did not fall into any distinct category (the 
filamentous biofilm associated gene tasA and the ABC transporter gene oppA, GBAA3645).  
In contrast, 38 genes were determined to be SinR-regulated during the stationary growth 
phase, with the largest class of genes annotated as conserved hypotheticals (Fig. 4-2C). 
Additional classes of SinR-regulated genes during stationary phase are genes involved in 
sporulation (five, including spoIIE and spoIIGA), metabolism (five), degradation (three), 
and regulation (two) genes (Table 4-2). 
 The promoter regions of the 41 unique genes identified as being sinR-regulated in B. 
anthracis were analyzed for sequence similarity to the deduced SinR consensus sequence 
from B. subtilis, GTTCTYT (Tables 4-1 and 4-2; (24)).  In B. subtilis the most conserved 
aspect of the consensus sequence is the spacing of the thymine residues (Fig. 4-3) (24). The 
promoter regions of SinR-regulated B. anthracis genes were searched for the conserved 
pattern, RTTXTXW, in which R is A or G and W is A or T.  B. anthracis sequences with 
similarity to the B. subtilis binding site were identified and aligned using the sequence logo 
program WEBLOGO (Univeristy of CA, Berkley) to determine the putative SinR-binding 
motif for the SinR protein of B. anthracis (Fig. 4-3).   
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Figure 4-3. Putative SinR binding motif derived from SinR-regulated genes of B. 
anthracis.  The putative consensus sequence for SinR binding, derived from sequences 
upstream of SinR-regulated gene in B. anthracis was aligned using the Weblogo program 
(University of CA, Berkley).   
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4.2.3. Comparison of the SinR regulons of B. anthracis and B. subtilis. In B. subtilis, the 
SinR regulon is comprised of at least 35 genes (7, 24, 25, 62, 78, 83, 88, 94, 99, 100, 152). 
Eighteen of these genes were identified in a transcriptional profiling experiment comparing 
sinR- to sinI-null mutants during exponential phase of growth (24). My transcriptional 
profiling data indicate only limited convergence of SinR-regulated genes from B. anthracis 
and B. subtilis (Fig. 4-4).  Interestingly, approximately half of the genes controlled by SinR 
in each species do not have homologues in the other species (e.g. 21 genes that are SinR-
regulated in B. anthracis have no homologue in B. subtilis).  Of the 35 genes regulated by 
SinR in B. subtilis, and the 41 genes regulated by SinR in B. anthracis, only four genes were 
common to both regulons (tasA, sipW, spoIIE, and spoIIG). Surprisingly, 16 SinR-regulated 
genes of B. subtilis have homologues in B. anthracis that did not exhibit differential 
expression in my transcriptional profiling experiment.  Likewise, 17 SinR-regulated genes of 
B. anthracis have homologues in B. subtilis that have not been reported as SinR–controlled 
in that species (Fig. 4-4).  As the putative SinR-binding motif in B. anthracis is highly 
similar to the B. subtilis SinR-binding consensus sequence (Fig. 4-3), it is unlikely that 
variation in the binding sequence accounts for the lack of convergence of the two SinR 
regulons.    
 
4.2.4. Specific binding of rSinR to promoter DNA. To determine if B. anthracis SinR 
binds specifically to promoter regions of target genes, Electrophoretic Mobility Shift Assays 
(EMSAs) were performed using rSinR purified from E. coli.  DNA probes corresponded to 
sequences upstream of the SinR-regulated genes calY, sipW, and inhA1, and a gene 
unaffected by sinR, npr599 (Tables 4-1 and 4-2). When 10nM or higher rSinR was present 
in the binding reaction, the gel mobility of the calY and sipW promoter probes was retarded 
compared to the free probe (Fig. 4-5).  Probes representing the non-SinR-regulated npr599 
promoter and the weakly (2.9-fold) regulated inhA1 promoter were not shifted, even when 
the rSinR concentration was increased to 4.2µM (data not shown). The analyses indicate that 
the B. anthracis SinR is a DNA-binding protein that binds specifically to the promoter 
regions of the highly-regulated target genes calY and sipW.  Given that inhA1 expression is 
elevated in a sinR-null mutant strain, as determined from the microarray data as well as 
quantitative RT-PCR (data not shown), I posit that regulation of inhA1 by SinR is either 
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Figure 4-4. Comparison of the SinR regulons of B. anthracis and B. subtilis. Total SinR-
regulated genes are indicated (exponential and stationary growth phases) from B. anthracis 
transcriptional profiling experiments (this study) and from B. subtilis literature (7, 24, 25, 
62, 78, 83, 88, 94, 99, 100, 152).  
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Figure 4-5. SinR specifically binds the promoters of sinR-regulated genes calY and 
sipW. EMSAs were performed using 0.1nM of probe DNA and increasing concentrations of 
purified rSinR protein, 0nM, 0.4nM, 2nM, 10nM, and 50nM.  npr599 promoter probe was 
used as a negative control. 
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Indirect or the affinity of SinR for the inhA1 promoter is greatly diminished compared to 
SinR affinity for the highly-regulated sipW and calY promoters.   
 
4.2.5. sin control of secreted proteases. Regulation of genes encoding the proteases 
camelysin and InhA1 by SinR is intriguing given that InhA1 has been implicated in B. 
anthracis virulence, and that homologues of camelysin produced by B. cereus and B. 
thuringiensis are active against host substrates (22, 23, 26-28, 59, 79, 106). Negative 
regulation of inhA1 by SinR is relatively weak (2.9-fold) and InhA has been reported to be 
an abundant protein in the B. anthracis secretome whereas calY is repressed 140-fold by 
SinR and does not appear to be a major component of the B. anthracis secretome (22).  
 I asked if InhA1 and camelysin protein levels reflect the effects of SinR on inhA1 
and calY transcription. The parent strain (7702) and sinR-, sinI-, and sinI/R-null mutants 
were cultured and cell pellets and supernates were collected at exponential (OD600 ≈ 1.6), 
transition (OD600 ≈ 3.1) and stationary (OD600 ≈ 3.1) phases of growth. Protein samples were 
assessed for camelysin, InhA1, and TasA (the product of a SinR-controlled gene that is 
common to B. subtilis and B. anthracis) using Western hybridization (Fig. 4-6).  Consistent 
with the transcriptional profiling data, the sinR mutant produced substantially higher levels 
of camelysin and TasA compared to the parent strain (Fig. 4-6). Moreover, camelysin and 
TasA levels in the sinI mutant were less abundant compared to the parent strain. These 
results are consistent with the B. subtilis model in which SinR regulates target gene 
expression and SinI inhibits SinR activity (155).  Unlike the results obtained for camelysin 
and TasA, InhA1 levels did not correlate with the transcriptional profiling data. Steady state 
levels of InhA1 were detected in the supernate of the parent strain during the stationary 
phase of growth, but surprisingly, InhA1 protein levels were decreased in the sinR mutant 
and elevated in the sinI-null mutant (Fig. 4-6). These experiments were also performed using 
a different strain background (Ames cured of pXO1 and pXO2) and identical results were 
obtained (data not shown). Taken together the data are indicative of a gene product under 
post-transcriptional regulation.  
 
 
 
 69 
 
Figure 4-6. Effects of B. anthracis sinR and sinI on Camelysin, TasA, and InhA1.  The 
parental strain 7702 and sinR-, sinI-, sinIR-mutnant derivatives (UT315, UT365, and 
UT371, respectively) were cultured in NBY and samples were taken during exponential 
phase, transition phase, and stationary phase of growth.  Cell pellets were sampled to assess 
camelysin and TasA, and proteins in the culture supernatant were sampled to assess InhA1.  
Western hybridization experiments were performed with camelysin, TasA, and InhA1 
specific antibodies. 
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 Further examination of InhA1 and camelysin levels during culture of the parent 
strain revealed that InhA1 and camelysin levels are inversely correlated during stationary 
phase. As camelysin levels decrease, InhA1 levels increase (Fig. 4-7A). To obtain a better 
understanding of the relationship between camelysin and InhA1, individual isogenic 
protease mutant strains were created and InhA1 and camelysin levels in the culture 
supernatant and cell pellet, respectively, were assessed using Western blot analysis. As 
shown in Fig. 4-7B, in early stationary phase, InhA1 levels were significantly higher in the 
calY mutant strain than in the parent strain, while camelysin levels were unchanged in the 
absence of inhA1. To negate the effects of sinIR-mediated control of calY on InhA1 levels, 
the calY gene was expressed from an IPTG-inducible promoter in a calY-null mutant 
background. Levels of InhA1 and camelysin produced in the presence of increasing 
concentrations of IPTG were determined using Western blot analysis (Fig. 4-7C). Again, 
camelysin and InhA1 protein levels were inversely related, as camelysin levels increased 
InhA1 levels decreased.  Taken together, these results indicate that InhA1 is degraded in 
supernates of cells in which camelysin synthesis is derepressed.   
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Figure 4-7. camelysin controls the level of InhA1 in culture supernates. (A.) 
Endogenous InhA1 and camelysin protein levels are inversely related.  Parental B. anthracis 
strain 7702 was cultured in NBY and samples were taken every 2 hours, beginning at the 
transition phase of growth. Shown are Western blots using antibodies against camelysin and 
InhA1. A corresponding growth curve of 7702 is included as a reference.  (B.) InhA1 is up-
regulated in a calY mutant strain, however camelysin levels are unaffected in an inhA1 
mutant strain.  Shown are Western blots of early stationary phase samples from the parent 
and inhA1- and calY-mutant derivatives, UT345 and UT356, respectively, using antibodies 
to InhA1 and camelysin.  (C.) Levels of camelysin produced by B. anthracis inversely 
correlate with InhA1 levels in the supernatant.  InhA1 and camelysin levels were detected in 
parent and calY mutant strains carrying empty vector (EV; pUTE973) and the calY mutant 
strain carrying the IPTG inducible calY (pUTE980).  Western blot analysis used antibodies 
specific to InhA1 or camelysin.  The abundance of calY and inhA1 relative to the parent 
strain, 7702 containing EV, were determined using densitometry analysis, the data are 
presented as fold-change.  
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4.3. Discussion 
 The common physiology of Bacillus species reflects their genomic synteny and gene 
sequence similarity (118, 140). Multiple metabolic and regulatory loci, studied primarily in 
the archetype species B. subtilis, have functional homologues in other Bacillus species. For 
these spore-forming bacteria, shared systems controlling cell development are particularly 
notable (8, 15, 38, 39, 49, 93, 95, 104, 132, 160). Here I examined function of the sinIR 
locus in B. anthracis. The comparable locus in B. subtilis was first characterized as part of 
the extensive sporulation network (55, 137). Subsequent studies revealed that B. subtilis 
SinIR plays a regulatory role in multiple growth-phase–associated phenotypes (24, 56, 62, 
94, 99). Results reported here reveal that the B. anthracis sinIR locus and the associated 
regulon exhibit some similarity to those of B. subtilis, but also significant differences.  
 The SinIR regulatory system is comprised of the DNA-binding protein SinR, that 
controls transcription of target promoters, and the SinR antagonist SinI, which when bound 
to SinR prevents its association with DNA (5). Given the similarity of the SinR and SinI 
amino acid sequences and data generated in this study, it is likely that the molecular 
mechanisms for function of the B. anthracis and B. subtilis proteins are equivalent. I have 
shown that B. anthracis SinR has specific DNA-binding activity for highly SinIR-regulated 
promoters, that SinIR-regulated genes of B. anthracis possess promoter DNA sequences 
with similarity to the SinR recognition sequence established in B. subtilis, and that a B. 
anthracis sinI-null mutant displays the expected phenotypes for SinR-controlled genes. 
 Differences in the SinR regulons of B. anthracis and B. subtilis appear to be 
primarily due to disparities in target genes encoded by each species. Approximately one half 
of the genes reported to be SinR-regulated in either B. anthracis or B. subtilis do not have 
homologues in the other species. Several SinIR-regulated genes of B. subtilis are associated 
with species-specific phenotypes including biofilm formation, motility, and competency (7, 
62, 88, 94).  In B. subtilis, SinIR negatively controls the biofilm-associated 
extrapolysaccharide genes (eps) and the biofilm structural protein gene yqxM (24). B. 
anthracis, which does not readily form biofilms, is missing these sinIR-regulated genes. 
Likewise, B. anthracis is non-motile and does not carry a homologue of the B. subtilis 
SinIR-regulated sigD gene (88), which encodes a transcriptional regulator of B. subtilis 
motility genes.  Two key competency genes, comS and srf, are SinIR-regulated in B. subtilis 
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(94), but absent in B. anthracis.  Finally, in B. subtilis a sinR parologue, slrR, has been 
demonstrated to work in tandem with SinR to regulate select targets (17, 18), however, a 
slrR homologue is not apparent in B. anthracis.  
 In B. subtilis and B. anthracis, several genes of the SinR regulon encode degradative 
enzymes, some of which are present in one species but not the other. Among these are the B. 
subtilis gene aprX, encoding a serine protease (152) and the B. anthracis genes inhA1 and 
calY, encoding the InhA1 and camelysin secreted metalloproteases, respectively.  The inhA1 
and calY genes are present in the B. cereus group members, B. anthracis, B. thuringiensis, 
and B. cereus. InhA1 was first identified as a B. thuringiensis protease that promotes 
survival of the bacterium in the hemolymph of infected insects (45, 136).  Subsequently it 
was shown that InhA1 degrades the cecropin and attacin insect antimicrobial peptides (33). 
Lereclus and coworkers (116) further demonstrated a link between InhA1 and the immune 
response by showing that InhA1 enhances escape of B. thuringiensis from macrophages. It is 
notable that in B. thuringiensis, overexpression of sinR results in repression of inhA1 
expression (58), in agreement with the B. anthracis data revealing increased inhA1 
expression in a sinR-null mutant. Similar to its orthologue in B. thuringiensis, InhA1 from B. 
anthracis cleaves a number of host proteins, including proteins involved in the coagulation 
cascade (including von Willebrand Factor and Pro-Thrombin) as well as extracellular matrix 
proteins (26-28, 79).  In addition InhA1 from B. anthracis alters the abundance of over half 
of proteins in the culture supernatant either directly, as in the case of the anthrax toxin 
proteins, or indirectly through its activity within a proteolytic regulatory cascade (see 
Chapter III).   
 Camelysin, the other SinR-regulated secreted protease of B. anthracis, was first 
described as a casein-lytic protein of B. cereus (59). Substrates of B. cereus camelysin 
include host cell matrix proteins such as collagen and actin, as well and proteins of the 
coagulation cascade (52).  A camelysin homologue in B. thuringiensis has been reported to 
activate Cyt2Ba, a protein toxin that exhibits activity against the Dipteran order of insects 
(106).  Function of the B. anthracis camelysin has not been described previously.   
 The degree of SinR-mediated transcriptional control of the B. anthracis inhA1 and 
calY genes differs considerably. The calY gene is the most highly over-expressed in the 
sinR-null strain compared to the parent and SinR directly binds the gene’s promoter region; 
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while inhA1 is only weakly regulated by SinR and I was unable to demonstrate binding of 
SinR to the inhA1 promoter region. The weak regulation of inhA1 by SinR is puzzling 
considering that the inhA1 promoter region harbors a sequence (GTTATAA) that is similar 
to the SinR recognition sequence established in B. subtilis (GTTCTYT) (24) and to 
sequences in the promoter regions of the highly-regulated B. anthracis genes. In B. subtilis 
and B. anthracis the number of putative SinR-binding sites upstream of individual SinR-
regulated genes varies from one to four. SinR may have a weak affinity for the inhA1 
promoter region due to the spacing or number (two) of putative binding sites. The highly 
SinR-regulated promoters examined in my study contain 1-3 putative binding sites (Table 4-
1). Alternatively, or in addition, the nucleotide mismatches in the recognition sequence may 
result in the weak regulation of inhA1 by SinR.  Finally, nucleotides outside of the 7bp 
putative binding site may also contribute to the strength of SinR binding. 
 Although SinR has a relatively small affect on inhA1 transcription, it has a large 
effect on InhA1 levels in culture supernates.  The data suggest that increased InhA1 in 
cultures of a sinI-null mutant is associated with SinR-mediated repression of calY 
transcription. When B. anthracis is cultured in rich complex media, InhA1 is one of the most 
abundant proteins in stationary phase culture supernates, while camelysin levels are 
relatively low (22). In a sinR-null mutant, InhA1 levels are reduced dramatically and 
camelysin levels are increased. Comparison of InhA1 and camelysin levels revealed an 
inverse relationship between InhA1 and camelysin, with InhA1 levels increasing as 
camelysin levels decrease. Moreover, when calY expression was artificially induced, a 
decrease in InhA1 was observed. Taken together, my data support a model in which InhA1 
is degraded by camelysin when calY gene expression is derepressed. 
InhA1 is a major component of the B. anthracis secretome that appears to degrade 
host and bacterial substrates with relatively little specificity (22, 26-28, 79). A system in 
which InhA1 levels are controlled transcriptionally and post-translationally in response to 
the growth-phase–associated activity of SinR suggests that limitation of InhA1 abundance is 
beneficial in certain environments. Interestingly, in B. thuringiensis inhA1 transcription is 
controlled by another growth-phase associated regulator, AbrB (58). The weak nucleotide 
sequence conservation of the reported AbrB recognition site (142, 159) makes it difficult to 
predict whether the inhA1 gene is similarly controlled by AbrB in B. anthracis. 
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Nevertheless, involvement of AbrB in addition to SinR in InhA1 expression would provide 
an interesting link between the protease and well established virulence factors of the 
bacterium. In B. anthracis, AbrB controls transcription of the pleotropic virulence gene 
regulator atxA (127, 142).  Future studies addressing the affects of transition state regulators 
such as SinIR on temporal expression of virulence genes in the context of infection and 
during B. anthracis growth in mammalian hosts and in other environments will further my 
understanding of target gene function. 
 The role established here for camelysin in the regulation of InhA1 provides evidence 
for an early step in the proteolytic regulatory cascade in B. anthracis (see Chapter III).  
Defining the progression of events of the regulatory cascade is necessary to obtain a 
fundamental understanding of the post-translational regulation of the extracellular proteins 
of B. anthracis.  The amplifying nature of a regulatory cascade provides the possibility that 
regulation by one of the cascade proteases has implications on processes from bacterial 
development to virulence. 
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Chapter V 
Characterization of the growth and virulence of an  
inhA-null strain of B. anthracis 
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5.1. Introduction 
 B. anthracis is a spore forming organism and the causative agent of anthrax.  Three 
forms of human anthrax infection have been described, each of which is characterized by the 
route of infection, cutaneous (the most common), inhalational (highest lethality rate), and 
gastrointestinal (139).  In each case the infectious form of B. anthracis is the spore.  Upon 
exposure to nutrients in the host the spore germinates and the vegetative form of B. 
anthracis spreads the disease either locally or systemically (139).  While cutaneous anthrax 
infections occur at higher frequency it is the inhalation form of disease that draws the most 
attention, in part due to the greater lethality rate associated with inhalational anthrax 
infections.  The working model for the progression of inhalational anthrax can be broken 
down into the following stages (Fig. 1-1): association of the spore with a phagocyte, spore 
germination, dissemination of vegetative cells, and the production of virulence factors (19).  
Without rapid treatment with antibiotics dissemination of the organism commonly results in 
sepsis, meningoencephalitis, and death (57).  It remains contentious whether the spore 
germinates within the lung, after phagocyte uptake, or upon transport to the regional lymph 
nodes.  An additional dissemination route is emerging as a secondary or alternative to the 
phagocyte-based model in which spores transverse the epithelial cell membrane prior to 
dissemination from the lung (125).  The anthrax toxin receptors (ANTRX1 and ANTRX2),  
cell-surface proteins that bind anthrax toxin protein leading to an alteration of host cell 
signaling pathways induced by specific toxin activities, are expressed by macrophages as 
well as epithelial cells located at each initial site of B. anthracis infection (lung, skin, 
intestine) (6, 9).  Thus, some spores may germinate prior to dissemination resulting in 
production of toxin at the initial infection site stimulating a change in host cell signaling.  
 The cellular innate immune response to inhalational anthrax infection includes 
important roles for dendritic cells and neutrophils, however macrophage are thought to be 
the key immune cell of the infection process (11, 32).  Mouse-derived primary macrophages 
and dendritic cells infected with B. anthracis result in the release of the important pro-
inflammatory cytokines IL-1, TNF-α, and IL-8 (11, 29, 113).  Furthermore, mice chemically 
depleted of macrophages show increased susceptibility to B. anthracis (32), emphasizing the 
importance of macrophages in controlling B. anthracis infection.  Association of B. 
anthracis spores with the macrophage is promoted through an interaction between the host 
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cell Mac-1 integrin and the B. anthracis exosporium protein BclA, an interaction that leads 
to phagocytosis of the spore (109). Pathogen-induced phagocytosis through macrophage 
cell-surface integrin binding is a common mechanism of pathogen:macrophage association 
(65, 75, 144), and it is possible that additional B. anthracis surface proteins may also 
promote this mechanism of entry.      
 Throughout infection B. anthracis, and other pathogens, are exposed to the activity 
of small cationic peptides, termed antimicrobial peptides (AMPs).  AMPs are produced by a 
variety of cell types, including neutrophils and macrophages.  Classically, AMPs are 
grouped based on structure and fall into three main classes, defensins (α and β), 
cathelicidins, and histanins (35, 63).  Although AMPs such as β-defensin 1 (HBD-1) and the 
human cathelicidin LL-37 are constitutively expressed in some cell types, the expression of 
other AMPs can be up-regulated in response to pro-inflammatory cytokines (35, 146).  The 
primary antibacterial mechanism of AMPs is membrane permeation via pore formation (35, 
148), leading to bacterial cell lysis.  In addition, some AMPs have chemoattractant activity 
towards immune cells, and are able to activate dendritic cells, induce granulocyte 
degranulation, and modulate phagocyte activity (35, 63, 148).  B. anthracis is susceptible to 
LL-37 and possibly other AMPs (146).   
 Survival of B. anthracis in the host is in part due to the immune evasion activities of 
anthrax toxin and of several secreted proteases.  Studies into the activity of Lethal Factor 
(LF) indicate that LF disrupts MAPK signaling pathways resulting in cell cycle disruption or 
apoptosis (103).  The secreted protease Immune Inhibitor A1 (InhA1) has also been 
implicated in enhancing B. anthracis virulence, through the cleavage of an array of 
substrates.  In vitro, purified InhA1 processes extracellular matrix proteins, including 
fibronectin and collogen, as well as proteins involved in the coagulation cascade, such as 
plasmin inhibitors and prothrombin (28, 79).  InhA1 also induces the expression of 
plasminogen activator inhibitor (PAI-1) in mice injected with purified InhA1 (26).  This 
modulation of coagulation proteins in the host results in an increase in the rate of clotting, as 
demonstrated in human blood incubated with either parent or an inhA1 mutant strain (79).  
The effects of InhA1 on host proteins may be particularly pertinent as InhA1 is one of the 
most abundant proteins secreted by B. anthracis in laboratory media, and is immunoreactive 
with the sera of infected animals (22, 23), suggestive of in vivo expression.  B. anthracis 
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encodes a homologue of inhA1, inhA2, whose gene product shares 67.7% amino acid 
identity to InhA1.  In contrast to InhA1, InhA2 has not been detected in secretome analysis 
of this organism.  However, InhA2 is detected by the immunesera of B. anthracis-infected 
animals and therefore is likely produced in the host (53).   
Here, I identify that inhA1 and inhA2 are transcribed under standard laboratory 
conditions and, perhaps of greater interest with respect to B. anthracis virulence, also under 
toxin-inducing conditions.  The InhA proteins may function both early and late during 
infection, as evident by an inhA1/inhA2-null mutant strain showing decreased association 
with macrophage-like cells (an early stage of infection), and attenuated lethality in a mouse 
intra-tracheal model of infection (early and late).  I also provide evidence that one 
mechanism by which the InhA proteases enhance B. anthracis virulence is through 
inhibition of the cathalicidin class of AMPs.   
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5.2. Results 
5.2.1. Homology of InhA1 and InhA2 in B. anthracis.  Alignment of the predicted amino 
acid sequences of InhA1 and InhA2 of B. anthracis indicate that the two proteins share high 
levels of homology (Fig. 5-1).  Identical regions of sequence between InhA1 and InhA2 
include the conserved zinc binding motif HEXXH (Fig. 5-1), a characteristic of zinc 
metalloproteases (64, 69).  Despite high levels of amino acid identity the two InhA proteins 
are not thought to be functionally redundant as several putative functional domains differ 
between the proteins (Fig. 5-1).  InhA2 but not InhA1 has a predicted lipobox at the amino-
terminus of the protein indicating that InhA2 may be a lipoprotein, and as such may be 
retained at the B. anthracis cell surface.  In addition, while both InhA1 and InhA2 contain 
putative integrin-binding motifs, InhA2 contains an arginine-glycine-aspartate (RGD) motif 
while InhA1 has a conserved substitution in the motif resulting in a KGD sequence.  The 
RGD motif is a binding ligand of an array of distinct integrins, cell surface receptors that can 
be specific to diverse eukaryotic cell types including macrophages, and binding can alter cell 
signaling and induce phagocytosis (73, 74, 124, 144).  The KGD motif has only been 
described as a ligand for αIIbβIII integrins, an integrin specific to platelet cells (124).  Thus, 
the different predicted motifs present in InhA1 and InhA2 indicate that the two proteins may 
have distinct functions during infection.  
 
5.2.2. Expression analysis of the InhA proteases.  InhA1 is highly abundant in the 
stationary phase secretome of B. anthracis grown in laboratory media (22).  In addition, 
InhA1 is present at a higher concentration in germinating spores than in dormant spores 
(71).  InhA2 has not been detected in in vitro secretome analyses of B. anthracis (2, 28), 
however antibodies in the sera of infected hosts react with InhA2, indicating that InhA2 is 
expressed in vivo (53, 87).  To begin to investigate differences in expression of the two 
proteins inhA1 and inhA2 transcripts levels were assessed using a quantitative RT-PCR 
approach. Transcript levels were assessed during growth in nutrient rich media at 37°C, both 
in air and in the presence of sodium bicarbonate with 5% CO2 (toxin-inducing conditions)  
(Fig. 5-2).  My data showed that inhA1 transcripts were significantly more abundant than 
inhA2 transcripts under each of the conditions tested (Figure 5-2A).  In addition, inhA1 was 
differentially expressed when cells were grown under atmospheric and toxin-inducing 
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                10        20        30        40        50        60        70 
                 |         |         |         |         |         |         | 
InhA1   -MNKKPFKVLSSIALTAVLGLSFGAGGQSVYAETPVNK---TATSPVDDHLIPEERLADALKKRGVIDSK 
InhA2   MRRKAPLKVLSSLAIAAIIGCTSVMSAPLAYAETPAKEKENVSTTPIDYNLIQEDRLAEALKERGTINPA 
                80        90       100       110       120       130       140 
                 |         |         |         |         |         |         | 
InhA1   ASEKETKKAVEKYVENKKGENPGKEVTNGDPLTKEASDFVKKVKDAKADTKEKLDKPATGTPAATGPV-- 
InhA2   SSKEETKKAVEKYIEKKQGDQANKEILPADT-AKEASDFVKKVKEKKMEEKEKVKKPEKNVSPEQKPEPN 
               150       160       170       180       190       200       210 
                 |         |         |         |         |         |         | 
InhA1   RGGLNGKVPTSPAKQKAYNGDVRKDKVLVLLVEYADFKHNNIDKEPGYMYSEDFNKEHYEKMLFGDEPFT 
InhA2   KKQLNGQVPTSKAKQAPYKGSVRTDKVLVLLVEFSDYKHNNIDQTPGYMYSNDFSREHYQKMLFGNEPYT 
               220       230       240       250       260       270       280 
                 |         |         |         |         |         |         | 
InhA1   LDDGSKIETFKQYYEEQSGGSYTVDGTVTKWLTVPGKAADYGADAATGHDNKGPKGPRDLVKDALKAAVD 
InhA2   LFDGSKVKTFKQYYEEQSGGSYTTDGYVTEWLTVPGKASDYGADGSSGHDNKGPKGARDLVKEALHAAAE 
               290       300       310       320       330       340       350 
                 |         |         |         |         |         |         | 
InhA1   SGLDLSEFDQFDQYDVNGDGNKNQPDGLIDHLMIIHAGVGQEAGGGKLGDDAIWSHRWTVGPKPFPIEGT 
InhA2   KGLDLSQFDQFDRYDTNSDGNQNEPDGVIDHLMVIHAGVGQEAGGGKLGDDAIWSHRSKLAIDPVAIEGT 
               360       370       380       390       400       410       420 
                 |         |         |         |         |         |         | 
InhA1   QAKVPYWGGKMAAFDYTIEPEDGAVGVFAHEYGHDLGLPDEYDTQYSGHGEPVQAWSIMSGGSWAGKIAG 
InhA2   KSKVDYFGGKVAAHDYTIEPEDGAVGVFAHEFGHDLGLPDEYDTKYTGTGSPVEAWSLMSGGSWTGKIAG 
               430       440       450       460       470       480       490 
                 |         |         |         |         |         |         | 
InhA1   TTPTSFSPQNKEFFQKTIGGNWANIVEVDYEKLNKGIGLATYLDQSVTKTNRPGMIRVNLPDKDIKTIDP 
InhA2   TEPTSFSPQNKDFLQKNMGGNWAKILEVDYDKIKRGVGVPTYIDQSVTKSNRPGVVRVNLPGKSVETIKP 
               500       510       520       530       540       550       560 
                 |         |         |         |         |         |         | 
InhA1   AFGKQYYYSTKGDDLHTKLETPLFDLTNATTAKFDFKSLYEIEAEYDFLEVHAVTEDGQQTLIERLGEKA 
InhA2   EFGKHAYYSTRGDDMHTTLETPFFDLTKGTNAKFDYKANYELEAECDFVEVHAVTEDGTKTLIDRLGEKV 
               570       580       590       600       610       620       630 
                 |         |         |         |         |         |         | 
InhA1   NNGNADSTNGKWIDKSYDLSQFKGKKVKLTFDYITDGGLALNGFLLDNASLTVDGKVVFSDDAEGTPQFK 
InhA2   VQGDKDTTDGKWIDKSYDLSQFKGKKVKLQFDYITDPAVTYKGFAMDHVNVTVDGQVVFSDDAEGQSKMN 
               640       650       660       670       680       690       700 
                 |         |         |         |         |         |         | 
InhA1   LDGFAVSNGTEKKSHNYYVEWRNYAGSDNALKFARGPEYNTGMVVWYADSAYTDNWVGVHPGHGFLGVVD 
InhA2   LNGFVVSDGTEKKAHYYYLEWRNYAGSDNGLKAGKGPVYNTGLVVWYADDSFKDNWVGVHPGEGFLGVVD 
               710       720       730       740       750       760       770 
                 |         |         |         |         |         |         | 
InhA1   SHPEAIVGTLNGKPTVESSTRFQIADAAFSFDKTPAWKVVSPTRGTYTYNGLAGVPKFDDSKTYINQQIP 
InhA2   SHPEAFVGNLNGKPTY-GNTGMQIADAAFSFDQTPAWSVNSLTRGQFNYSGLQGVTTFDDSKVYSNNQIA 
               780       790       800 
                 |         |         | 
InhA1   DAGRILPNLGLKFEVVGQADDNSAGAVRLYR 
InhA2   DAGRKVPKLGLKFQVVGQADDKSAGAVWIKR 
▼ 
▲ 
 
Figure 5-1.  Alignment of InhA1 and InhA2 predicted amino acid sequences.  Ames 
ancestor sequences aligned with the ClustalW program (31, 145).  Residues of the conserved 
zinc binding motif are indicated in the boxed sequence.  The predicted lipobox of InhA2 is 
highlighted in yellow and the integrin binding motifs are underlined.  Conservation of 
residues are color coded; red are identical (67.7%), green are strongly similar (16%), blue 
are weakly similar (8.1%), and black are different (8.2%). 
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Figure 5-2. Expression of inhA1 is dramatically higher than inhA2.  Transcripts were 
measured from samples taken during growth in air and under toxin-inducing conditions (5% 
CO2 and sodium bicarbonate).  (A.) Quantitative RT-PCR analysis of inhA transcript levels 
relative to the housekeeping gene gyrB from exponential to stationary phases of growth.  
(B.) Growth of B. anthracis in nutrient rich media in air and under toxin-inducing 
conditions. 
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conditions.  Increased transcript abundance under toxin-inducing conditions is a strong 
indicator that InhA1 is expressed in the host.  While inhA1 transcript levels correlate with 
protein expression patterns during growth under toxin-inducing conditions (Fig. 5-2A and 4-
4), transcription and steady state protein levels are uncoupled when cells are grown in air.  
inhA1 transcript levels peak in early stationary phase of growth (T6; Fig. 5-2A), however, 
InhA1 does not accumulate in the culture supernatant until late stationary phase (Fig. 4-6A), 
supporting the hypothesis that InhA1 levels are regulated post-transcriptionally.   
 
5.2.3. Characterization of inhA mutant strains.  To facilitate analysis of the contribution 
of InhA1 and/or InhA2 to B. anthracis virulence mutant strains lacking in one or both 
proteases were created.  The inhA genes were deleted using standard techniques that resulted 
in replacement of the inhA genes with antibiotic resistance cassettes (see chapter 2, section 
3).  Mutant strain construction was verified using PCR and sequencing.  
 The growth of the inhA1, inhA2, and inhA1/inhA2 mutant strains was assessed in air 
and under toxin-inducing conditions; each mutant was found to have comparable rates of 
growth to the parent strain (data not shown).  As InhA1 protein levels are elevated in the 
germinating spore (71), the germination rates of the parent and inhA mutant strains were 
assessed, using heat sensitivity, a characteristic of dormant spores, as a measure of 
germination (154).  Similar germination rates were found for each of the strains tested (data 
not shown).  To further assess the effects of the InhA proteins on the lifecycle of B. 
anthracis the sporulation efficiency of the parent and inhA mutant strains were assessed.  
While each of the mutants readily sporulated in sporulation medium (PA medium, phage 
assay medium) or nutrient yeast broth (NBY), the inhA1 mutant strain exhibited a 
sporulation defect in defined medium (CA medium, Casamino Acids medium) (Fig. 5-3).  
The difference in sporulation is apparent in micrographs; by 16 hours of growth the parent 
strain had been engulfed by the mother cell, forming light retractile sporangia (Fig. 5-3), 
while the inhA1 mutant strain did not reach the same stage in sporulation until 30 hours 
(data not shown).   
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Figure 5-3. InhA1 is necessary for efficient sporulation in defined media.  The parent 
strain (Ames cured of plasmids pXO1 and pXO2), and the inhA1-null derivative strain were 
cultured in nutrient rich (NBY) and defined (CA) media for 16 h.  Cell development was 
assessed using microscopy and the relative presence of light-retractile spores was rated. 
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 Despite extensive efforts to complement the constructed inhA1 mutant strains I was 
unsuccessful.  The recovery of only small numbers of E. coli transformants, each of which 
harbored mutations within the cloned inhA1 gene, is consistent with this gene being lethal in 
E. coli.  Similar cloning attempts were made using B. subtilis as a cloning host but this also 
resulted in the recovery of colonies with mutated inhA1 genes.  I was able to express an 
exogenous copy of inhA1 in an inhA1-null strain of B. anthracis using an expression vector 
(pBSmul1) (13).  However, while B. anthracis cells containing this inhA1 construct were 
viable, the cells had a significant growth defect (data not shown).  Therefore, the 
“complemented” strain could not be used in my expression studies nor in subsequent 
experiments.  The inhA2 gene driven by its native promoter was easily cloned and integrated 
into the chromosome of B. anthracis at the plcR locus, a non-functional gene in B. anthracis, 
(generating strain UT306).  
  
5.2.4. InhA proteases contribute to the initial association of B. anthracis with 
macrophages.  The contribution of InhA1 and InhA2 early in infection was examined using 
a macrophage-association model of infection.  J774A.1 mouse macrophage-like cells were 
infected with spores of the B. anthracis parent strain 7702, inhA single mutant strains, or an 
inhA1/inhA2 double mutant strain.  Two separate cell populations were examined over time, 
the total population and the macrophage-associated population.  The total population 
consisted of all the bacteria in the infection (macrophage-associated and free bacteria), while 
the macrophage-associated population consisted of only those bacilli associated with the 
macrophages (intracellular and dormant spores), with macrophage-associated cells being 
differentiated by their resistance to the antibiotic gentamicin.  Figure 5-4A is a 
representative set of data obtained from an infection comparing the parent strain and the 
inhA1/inhA2 double mutant strain.  The data show that the population of macrophage-
associated bacilli remains constant throughout the course of the experiment irrespective of 
the presence/absence of the inhA genes.  Thus, the inhA genes do not contribute to the ability 
of B. anthracis to remain internalized.  This is contrary to similar experiments in B. 
thuringiensis, which is able to escape from the infected macrophage when expressing inhA1 
(116).  Interestingly, despite similar trends in the total and macrophage-associated 
populations for each strain throughout the course of the experiment (Fig. 5-4A), a phenotype 
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Figure 5-4. inhA mutant strains are attenuated in associated with mouse macrophage-
like cells.  (A.) The parent, 7702, and an inhA1/2-mutant derivative, UT284, were incubated 
with mouse macrophage-like cells and the number of bacilli associated with the 
macrophages, as well as the total number of bacilli in the well, was assessed over time.  
Solid bars represent macrophage-associated bacilli and hatched bars represent the total 
number of bacilli. Trends remain consistent between parent and inhA1/2 mutant strains.  (B.) 
Initial association of bacilli (T0) with macrophages, normalized to that observed with the 
parent strain.   
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consistently found at T0 was an approximate 10-fold difference in macrophage-association 
of the parent strain and the inhA1/inhA2 double mutant strain (Fig. 5-4B).  An analysis of 
the percentage of inoculated spores that were macrophage-associated at T0 indicated that a 
similar phenotype was also observed for each of the inhA single mutant strains (Fig. 5-4B).  
The data indicate that both InhA1 and InhA2 contribute to B. anthracis:macrophage 
association. 
 
5.2.5. InhA1 and/or InhA2 protects against the activity of some cathelicidin 
antimicrobial peptides.  The InhA1 orthologue in B. thuringiensis degrades the insect 
antimicrobial peptides cecropins and attacins to promote infection (33).  To test whether 
InhA1 and/or InhA2 play a role in the defense of B. anthracis against the cathelicidin class 
of antimicrobial peptides (AMPs), the resistance of a fully virulent strain (Ames) of B. 
anthracis and an inhA1/inhA2 isogenic mutant strain were assessed against LL-37 (human), 
CRAMP (mouse), protogrin 1 (pig), and cecropin A (insect) AMPs using a radial diffusion 
assay.  From the data I infer that InhA1 and/or InhA2 promote the resistance of B. anthracis 
to CRAMP and Cecropin A, but not to LL-37 or Protogrin 1 (Table 5-1).  Differences in 
protection afforded by the InhA proteins to various AMPs may be due to the fold of the 
mature AMP and the ability of the InhA proteases to access cleavage sites within the folded 
peptide.  It remains to be tested whether other representative human AMPs can be cleaved 
and inactivated by the InhA proteins.  
 
5.2.6. An inhA1/inhA2 double mutant strain is attenuated in a murine inhalational 
model of infection.  To assess the contribution of InhA1 and/or InhA2 to B. anthracis 
virulence I used an intra-tracheal mouse model of infection (97).  BALB/c mice were 
infected with a fully virulent strain (Ames) of B. anthracis or an inhA1/inhA2 isogenic 
mutant.  Infection was assessed using LD50 and mean time-to-death.  Survival curves 
identified that the inhA1/inhA2 mutant strain was significantly less virulent than the parent 
strain (Fig. 5-5).  While survival differences between the mice infected with the two strains 
were reduced at higher inoculums, the mutant strain never-the-less was consistently  
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Table 5-1. Minimal inhibitory concentrations of members of the cathalocidin class of 
antimicrobial peptides against the parent and inhA1/2 (UTA7) strains using a radial diffusion 
assay.   
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Figure 5-5. InhA proteins contribute to B. anthracis virulence in a mouse model of 
infection.  Mice were infected with one of two doses of the parent (Ames; green) or the 
inhA1/2 mutant strain (UTA7; red).  N=10 for each strain in each experiment. Survival 
curves generated using GraphPad Prism are representative of data collected from 2 
experiments.  Statistical significance was determined using logrank test. 
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attenuated.  The trend of decreased virulence in the mutant strain was also apparent from the 
LD50 data (Table 5-2).  The data are consistent with InhA1 and/or InhA2 contributing to the 
virulence of B. anthracis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 91 
Table 5-2. Lethal Dose50 of the parent (Ames) and inhA1/2 (UTA7) using a mouse intra-
tracheal model of infection, n=10 for each experiment. 
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5.3. Discussion 
 The progression or stages of anthrax disease coincide with the progression of 
bacterial development in the host, from dormant spore in the alveolar space of the lung to 
the vegetative cell actively secreting virulence factors in blood and tissue.  My data indicate 
that the InhA proteins may contribute to multiple stages of infection.  InhA1 and InhA2 
contribute to association with macrophage-like cells, an event early in infection.  By 
enhancing the B. anthracis-macrophage association, the InhA proteins may advance the 
efficiency of the initial dissemination from the lung, augmenting the ability of the bacterium 
to cause disease.  Given that B. anthracis is likely exposed to the membrane-disrupting 
activity of antimicrobial peptides throughout infection, produced by epithelial, myeloid 
precursors, and other cell types (63, 91, 121), the protective activity of the InhA proteins 
against AMPs may contribute to bacterial survival both early and late in the infection 
process.  Due to the general activity attributed to InhA1 it is conceivable that InhA1 protects 
against a wide array of AMPs that are produced throughout infection, the effectiveness of 
which should be assessed in future experiments. 
 InhA1 activity has also been proposed late in infection (during dissemination) as the 
protease modulates important factors of the coagulation cascade (26, 28, 79).  In addition to 
directly affecting virulence through interaction with host proteins InhA1 may affect 
virulence through the processing of bacterial substrates.  InhA1 significantly modulates the 
secretome of B. anthracis, directly cleaving the anthrax toxin proteins, thereby affecting the 
timing of toxin accumulation.  While anthrax toxin significantly influences the ability of B. 
anthracis to survive in the host (66), the affect of over expressing toxin in specific host 
tissues has not been assessed and may detrimentally impact the progression of the infection.  
As a member of a proteolytic cascade InhA1 affects the activity of numerous B. anthracis 
proteases, including Npr599, greatly inflating the effects of InhA1 on proteins secreted by B. 
anthracis.  Taken together these processing events may affect multiple stages of infection.  
The inhA double mutant strain is attenuated in the mouse intra-tracheal model of infection; 
however the degree of influence of each of the aforementioned activities on infectivity has 
not been determined.  That said it is likely that the decreased association of the inhA mutant 
strains with macrophages would directly impede the progression of disease and result in the 
attenuated phenotype of the inhA mutant strain. The vast difference in inhA1 and inhA2 
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transcript levels in vitro suggest that the attenuated phenotype in the mouse can, at least in 
part, be attributed to the deletion of the inhA1.  However, transcript levels have not been 
assessed in vivo and given that both proteins are expressed in the host, as assessed antibodies 
in the sera of infected animals (23, 53), the difference in inhA1 and inhA2 steady state 
transcript levels may be reduced in the host.   
 InhA1, and to a lesser extent InhA2, have been implicated in numerous processes, 
suggestive of roles in survival and virulence.  The InhA proteins are classified as zinc 
metalloproteases, however it may be more pragmatic to think of InhA1 and InhA2 as 
multifunctional proteins with proteolytic activity.  While the proteolytic activity of InhA1 
has been clearly defined (see chapter III and (27, 28)), the presence of a putative integrin 
binding motif within the primary amino acid sequence is suggestive of further protein 
functions.  If the KGD residues within the InhA1 sequence are surface exposed, InhA1 
could bind the platelet glycoprotein IIbIIIa (αIIbβIII integrin) (124) inhibiting clot formation 
and furthering the involvement of InhA1 in the coagulation cascade during the infection 
process.  A similar activity has been suggested for the S. pyogenes integrin-binding protease 
SpeB (141).   Unlike InhA1, proteolytic activity has not been confirmed for InhA2 in B. 
anthracis or other related species, however InhA2 does act synergistically with the B. 
thuringiensis toxin proteins to cause virulence through an undefined mechanism (47, 48).  
Here I show that a strain of B. anthracis with an inhA2 deletion is deficient in macrophage-
association.  I propose that InhA2 uses the unique lipobox as well and the predicted RGD 
motif to bind phagocyte integrins, such as CD11b/CD18 and induce bacterial:macrophage 
association, as is the case of the filamentous hemagglutinin protein in Bordetella pertussis 
(65).  As multifunctional proteins, InhA1 and InhA2 appear to be important contributors to 
the lifecycle of B. anthracis.   
 In addition to the postulated role of the InhA proteins in the host, a role for InhA1 in 
survival outside of the host can be posited from the sporulation defect of the inhA1 mutant 
strain in defined medium, a limiting environment.  As sporulation is a survival mechanism 
there are several possible scenarios that may explain the delay in sporulation of the inhA1 
mutant strain and the possible role of InhA1 in sporulation.  In the absence of InhA1 a toxic 
substrate may build in abundance, slowing the progression into sporulation.  Alternatively, 
InhA1 may be degrading extraneous substrates in the environment, thereby providing for 
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additional nutrients.  While the posited limited nutrients in the inhA1 mutant strain would 
affect the fitness of the organism, it is counterintuitive that this would delay sporulation.  
Finally, cleavage by InhA1 may lead to the activation of a protein necessary for the 
sporulation process.  Given the number of secreted proteins that are either directly or 
indirectly altered by InhA1, including a number of transporters, metabolic enzymes, and 
environmentally significant proteins (e.g. chitin associated), and that sporulation is merely 
delayed and not aborted, suggests that InhA1 is the primary, but not sole protease, that is 
necessary for a cleavage event that allows for progression into sporulation.  An additional 
role for InhA1 in the environment may be the inhibition of the architecture necessary for 
biofilm formation.  The soil bacterium and archetype of the Bacillus species B. subtilis 
actively produces biofilms, a process that is regulated by the SinIR proteins (24, 80).  In B. 
anthracis inhA1 is located just upstream of sinIR and is regulated the by SinR (Chapter IV).  
The expression and subsequent activity of InhA1 may partially be responsible for the limited 
ability of B. anthracis to produce biofilms.  Further research into the involvement of 
proteases in the B. anthracis lifecycle (spore to vegetative cell to spore) is necessary. 
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 Bacteria secrete an array of proteins that enhance the virulence and/or survival of the 
organism.  Regulation of secreted protein abundance is key to ensure appropriate timing of 
protein activity.  Here I provide evidence that expression of the secreted Bacillus anthracis 
protease InhA1 is regulated at both the transcriptional and post-translational levels.  InhA1 
accumulation in culture supernate has major effects on the composition and abundance of 
other secreted proteins of B. anthracis, including each of the three anthrax toxin proteins and 
the protease Npr599.  The potential contribution of InhA1 to B. anthracis virulence is 
indicated from the attenuated virulence of an inhA mutant strain in a mouse inhalational 
model of infection. 
 In chapter III I assessed how InhA1, directly or indirectly, modulates the secretome 
of B. anthracis.  Data from a proteomic analysis indicated that InhA1 affects the abundance 
of more than half of the proteins in the culture supernatant.  The identities of 96 proteins 
represented in the Differential in Gel Electrophoresis (DIGE) analysis were determined.  
The focus of the study was on proteins affected by InhA1 activity, hence proteins that were 
more abundant in the inhA1 mutant background were primarily chosen for identification.  
Proteins from numerous functional classes were determined to be InhA1-regulated, 
including proteins involved in peroxide reduction, chitin degradation and proteins with 
proteolytic activity.   
 Importantly, the DIGE analysis indicates the possible existence of a proteolytic 
regulatory cascade in B. anthracis, in which a given protease activates or disrupts the 
activity of another protease, which in turn activates or disrupts additional proteases.  This is 
suggestive from the fact that the steady state protein levels of eight proteases (including 
Npr599, the most abundant supernatant protein) were altered following inhA1 mutation.  
InhA1 directly cleaves Npr599, as determined using in vitro protease cleavage assays with 
purified proteases, and may also directly cleave other proteases in the cascade.  The 
abundance of only two proteases was unaffected by inhA1 mutation.  Thus, the data suggest 
that if a proteolytic regulatory cascade is utilized by B. anthracis then InhA1 acts in a key 
position within the cascade to directly or indirectly affect the abundance and/or activity of a 
substantial number of proteolytic enzymes.  The general activity attributed to InhA1 would 
suggest that InhA1 acts late in the cascade and may abort the activity of the other proteases 
in the cascade.    An alternative to the cascade model is the possibility that InhA1 acts in a 
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protease complex in which the proteases act in tandem and enhance the activity of other 
proteases.  The models could be differentiated by assaying for an increase in the specific 
activity of each protease in the absence of cleavage of the proteases using in vitro assays. 
The events in either model should be further elucidated.   
 While InhA1 cleaves an array of substrates it does, however, retain some level of 
substrate specificity.  This is evident from the fact that not all proteins in the DIGE analysis 
had altered abundance, as well as from in vitro protease assays using purified InhA1 protein 
which showed that InhA1 does not cleave the B. anthracis superoxide dismutase protein, 
SODA-1.  To date the specific cleavage recognition sequence or structure has not been 
determined.  The broad spectrum of substrates susceptible to InhA1, as described here and in 
published literature (27, 28), indicates that the protease acts as what has been termed a 
“general protease”.  General proteases commonly cleave both bacterial and host / 
environmental proteins.  While the InhA1-mediated cleavage of proteins during the 
environmental stage of the B. anthracis lifecycle (spore to vegetative cell to spore) has yet to 
be assessed, a function of such activity could be to utilize degradation products as an energy 
source.    
 My DIGE analysis indicated that InhA1 affects the accumulation of the majority of 
proteins secreted by B. anthracis when cultured under atmospheric conditions.  
Subsequently, I determined that InhA1 has an equally significant role when strains were 
cultured with 5% CO2 with sodium bicarbonate, conditions that are inductive for toxin 
production (51, 84).  Elevated CO2 and bicarbonate signals are considered to be an 
important cue for the bacterium during infection of mammalian host tissues.  During the 
exponential phase of growth under toxin-inducing conditions the most abundant proteins in 
the culture supernatant are the anthrax toxin proteins (PA, EF, and LF), with these proteins 
being depleted as the cell progresses into stationary phase (85).  The toxin protein 
expression pattern is drastically altered in the inhA1 mutant strain, with the toxin proteins 
remaining abundant throughout stationary phase, indicating that toxin protein degradation is 
dependent upon InhA1.  The timing of toxin protein degradation corresponds to InhA1 
protein expression, as under toxin-inducing conditions InhA1 is found in the culture 
supernatant from transition through stationary phases of growth.  Results from in vitro 
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protease assays showed that regulation of toxin protein abundance by InhA1 was direct, with 
the protease degrading all three of the toxin proteins.   
 One model for toxin protein activity dictates that the monomeric form of PA binds 
host cell receptors prior to cleavage by the host protease, furin, heptamer formation, and 
binding of the EF and/or LF proteins (30).  InhA1 preferentially cleaves after two amino 
acids (308 and 416) within unstructured loops of domain 2 of PA (89, 112).  Importantly, 
InhA1 cleaves PA at sites separate from the furin cleavage site (82, 105).  Domain 2 of PA 
not only functions as a linker region between the EF/LF binding site of domain 1 and the 
receptor binding site of domain 4 but also contains an unstructured loop that inserts into the 
host cell membrane prior to the translocation of EF and/or LF (89).  Cleavage by InhA1 may 
disassociate the binding activities of PA as well as alter the confirmation of PA increasing 
the susceptibility of PA to proteolytic activity.  Structural analyses of PA in monomeric and 
heptameric states suggest that the InhA1 cleavage sites may only be accessible in the PA 
monomeric form (89, 112).   
 Given the dramatic alteration of the B. anthracis secretome by InhA1, the expression 
of this protease was hypothesized to be tightly regulated.  In chapters IV and V the 
expression and regulation of the inhA1 transcript and protein levels were discussed.  The 
expression of the InhA1 protein under toxin-inducing conditions correlates with transcript 
levels of inhA1 which are elevated late in exponential phase and throughout stationary 
phase.  However, when cultured under atmospheric conditions the steady state levels of 
inhA1 transcript peak as the cells enter stationary phase while protein levels are not readily 
detectible until late in stationary phase.  Taken together, the divergent transcript and protein 
data indicate that one or more post-transcriptional regulatory event(s) regulate InhA1 
expression.   
 Using whole-genome expression microarrays I determined that the regulatory protein 
SinR regulates the transcript levels of 41 genes in B. anthracis, including negative regulation 
of inhA1 transcript levels.  The SinI/R regulatory proteins are conserved among Bacillus 
species.  In B. subtilus, SinR is a DNA-binding protein that regulates transcription of target 
genes during exponential growth, while SinI is an antagonist of SinR that inhibits SinR 
activity upon transition into stationary phase (5, 133).  To test whether the B. anthracis SinR 
protein also possessed DNA-binding activity I performed electrophoretic mobility shift 
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assays.  Recombinant SinR protein from B. anthracis bound specifically to the promoter 
regions of two highly SinR-regulated genes (calY and sipW) but not to the promoter regions 
of the negative control gene npr599 or inhA1.  Thus, it appears that SinR only weakly binds 
the putative binding motif upstream of inhA1 or that the regulation of inhA1 transcript levels 
by SinR is indirect. 
 Post-transcriptionally, InhA1 is subjected to multiple mechanisms of regulation.  The 
activity of InhA1 is likely dependent on a processing event, an event that is hypothesized to 
be auto-proteolytic in nature.  In addition, InhA1 levels are inversely proportional to the 
levels of the secreted protease camelysin.  Similar to inhA1, the camelysin-encoding gene, 
calY, is only found in the genomes of pathogenic members of the Bacillus genus, and is 
regulated by SinI/R.  Under atmospheric conditions camelysin is detected from the transition 
to stationary phases of growth.  As the cell progresses through stationary phase camelysin 
levels are depleted.  My data are consistent with camelysin reducing the abundance of InhA1 
in the culture supernatant under atmospheric conditions, limiting detectible levels of InhA1 
to a late stage of stationary phase growth.  The regulation of these proteolytic enzymes has 
yet to be addressed under toxin-inducing conditions.   
 I have presented evidence for a model in which a series of regulatory steps are used 
to control the activity of InhA1 (Fig. 6-1).  InhA1 is regulated transcriptionally and post-
translationally by the Sin proteins during growth under atmospheric conditions.  
Transcription of the inhA1 gene is inhibited by SinR during exponential phase.  Upon 
transition to stationary phase, inhibition of SinR by SinI alleviates repression and inhA1 is 
expressed.  Following translation and secretion, InhA1 is degraded in the culture supernatant 
by the SinR-regulated protease camelysin, reducing InhA1 activity in the culture 
supernatant.  As the cells progress through stationary phase camelysin levels decrease 
allowing for an accumulation of InhA1 and subsequent InhA1 activity.  The possible 
existence of the proteolytic cascade outlined in chapter III implies that similar regulatory 
mechanisms are responsible for maintaining control of other proteases secreted by B. 
anthracis.   
 Employing multiple levels of regulation of secreted proteins is to the organism’s 
advantage, enabling modulation of protein levels in response to a greater number of signals 
than is achievable through a single level of regulation.  The ability to post-translationally  
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Figure 6-1. Model of the regulation of InhA1.  SinI/R regulate expression of inhA1 and 
calY, limiting gene expression to transition and stationary phases of growth.  Post-
translationally, InhA1 levels in the culture supernatant are inhibited by Camelysin via 
proteolysis, resulting in an accumulation of InhA1 substrates, represented here by the Toxin 
proteins.  As the cells progress through stationary phase camelysin levels decrease allowing 
for an accumulation of InhA1 and subsequent InhA1 activity.  Solid shapes signify active 
proteins, while spottled shapes signify cleaved (inactive) proteins. 
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regulate proteins via proteolysis provides for a level of negative regulation once a gene is 
transcribed and translated, of particular importance when rapid turn-over of protein activity 
is necessary.  This may be the case in the host; the beneficial nature of elevated toxin levels 
may be limited to certain time points in infection or at niches in the host, making InhA1 
activity critical for progression of disease.   
 The timing of InhA1 expression, and subsequent activity, may be critical during 
infection.  The progression of anthrax disease can be correlated with bacterial development 
and expression of virulence factors in the host.  The established model for the progression of 
inhalational anthrax is that once spores enter the lung they are transported to the regional 
lymph nodes by phagocytes, at which point the spores germinate. The vegetative cells 
disseminate throughout the host ultimately resulting in septic shock and death (139).  The 
characterized virulence factors produced by B. anthracis, the anthrax toxin proteins and the 
poly γ-D-glutamic acid capsule, are produced during dissemination (86, 96, 98).  The 
involvement of the InhA proteins in B. anthracis virulence was addressed in chapter V using 
inhA1, inhA2 (a homologue of inhA1), and inhA1/inhA2 mutant strains.  The inhA1/inhA2 
mutant strain was attenuated in an intra-tracheal mouse model of infection, indicating that 
InhA1 and/or InhA2 contribute to the infection process.  As only the double mutant strain 
was assessed in the mouse, the phenotype of the single mutants will need to be assessed in 
future experiments to determine if the affect of the InhA proteins is due to a single protein or 
if the affect is cumulative.   
 Given that InhA1 regulates the timing of the steady state levels of the anthrax toxin 
proteins in culture supernatant, it would be interesting to assess the regulation of toxin 
protein levels in vivo. Changes in PA accumulation in the blood of infected animals in 
response to secreted InhA1 could be measured using an ELISA assay (98) and utilized as a 
marker to monitor InhA1 activity in the host.  An extension of the current study would be to 
map the temporal expression of each of the proteases that constitute the putative B. anthracis 
proteolytic cascade, including InhA1, in the host.  In addition to furthering our 
understanding of the regulation of the secreted proteins of B. anthracis, such research would 
provide insight into which, if any, of the proteases may make attractive therapeutic targets.   
 In addition to the putative role of InhA1 in regulating toxin protein levels in the host, 
the attenuated virulence of the inhA1/inhA2 mutant strain may be due to these proteins 
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contributing to an early stage of infection, the association of B. anthracis with macrophages.  
As macrophages are thought to be necessary to transport spores from the site of infection to 
regional lymph nodes (19), a defect in association with the macrophage may lead to 
attenuated virulence.  In a macrophage-association model utilizing unencapulated strains of 
B. anthracis I determined that each of the single inhA mutants as well as the double mutant 
exhibited a defect in association.  As the capsule of B. anthracis is anti-phagocytic in nature 
(81) and may mask the affects of the InhA proteins an unencapsulated strain background 
was used in this study.  The strong phenotype in the inhA2 mutant strain was surprising 
considering that inhA2 steady state transcript levels are >1000-fold lower than that of inhA1 
under toxin-inducing conditions, conditions that are thought to mimic physiologic conditions 
in the host.  However, these data, along with published reports that antibodies to InhA2 are 
present in the sera of the infected host (53, 87), indicate that inhA2 transcript levels may be 
elevated in the animal, and therefore both inhA1 and inhA2 transcript levels should be 
assessed in vivo. The contribution of InhA1 and InhA2 in host-cell-association appears to be 
additive. Despite the two single mutant strains having similar phenotypes, the two proteins 
may not be functional homologues as assessed by differences in functional motifs predicted 
from the primary amino acid sequence of the two proteins.   
 Bioinformatic analysis of the InhA1 and InhA2 predicted amino acid sequences 
revealed that the zinc-binding motif (HEXXH) is conserved in both proteins.  InhA2 
contains two putative motifs that are absent in InhA1 that may differentiate the activities of 
the two proteins.  InhA2 encodes a lipobox motif, a motif that promotes tethering of proteins 
to the bacterial cell membrane, and an RGD or integrin binding motif, which could facilitate 
interactions between B. anthracis and host cell integrins.  Considering the differences in the 
predicted amino acid sequences of the homologues it is conceivable that the InhA proteins 
differentially contribute to B. anthracis-macrophage association.  InhA1 may process 
surface exposed proteins enhancing the ability of the target protein to associate with the 
macrophage or prolong bacterial survival using its demonstrated proteolytic activity against 
both host and bacterial substrates ((28) and chapter III); while InhA2 may be cell surface-
associated and as such facilitate interactions with host cell integrins to aid in host cell 
association.  As these activities would result in a similar phenotype in the macrophage-
association assay the proteins would appear, incorrectly, to be functionally redundant.  The 
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activity of the InhA proteins could be differentiated experimentally, for example by 
assessing integrin binding by the two proteins.     
 From the data presented in this work I posit that the secreted proteases of B. 
anthracis form a global regulatory mechanism used to modulate the abundance of 
extracellular proteins. Given that several of these proteases are present only in the 
pathogenic members of the Bacillus genus, that proteases are highly abundant in B. 
anthracis cultures, and that an inhA1/inhA2 double mutant strain is attenuated in a mouse 
model of infection, these data all point to the secreted proteases playing key roles in the 
lifecycle of B. anthracis.  By regulating extracellular protein activity B. anthracis may better 
adapt to the changing environment, enhancing the survival and/or virulence of the pathogen. 
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